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Abstract 
 
 Vibrio cholerae, a member of the Vibrionaceae family, is notorious as the causative agent 
of acute gastrointestinal disease known as cholera. Genetic information in members of the 
Vibrionaceae family is distributed between two chromosomes that are distinctively maintained. 
In V. cholerae, the initiation of DNA replication in each chromosome involves distinct processes. 
While the initiation of replication  of chromosome I is carried by DnaA, the initiation of 
chromosome II replication is controlled by RctB, a DNA-binding protein that is an exclusive 
attribute of all Vibrio species. RctB has no homologs among other members of bacteria proteins 
and can serve as a target for designs of Vibrio-specific antibacterial medications. Elucidation of 
the molecular structure of RctB will facilitate the development of such medications. In this 
report, we describe results of several experiments that involve the growth of protein crystals for 
future X-ray crystallography studies aiming to disclose the structural components of RctB. 
 
Introduction 
 
 Vibrio cholerae is a gram-negative, facultative anaerobic bacterium in the shape of a rod 
of approximately 1.4 to 2.6 m in length (Nair et al, 2002). This bacterium is a member of the 
Vibrionaceae family. Typical ecological niches of Vibrio species include estuaries and marine 
environments, as well as fresh water reservoirs, where concentration of sodium ions is suitable 
for Vibrio growth.  Several factors that affect the reproduction of Vibrio colonies include 
chemical composition of water, pH, temperature, salinity, oxygen tension, and exposure to 
ultraviolet light (Huq et al, 1984; Nair et al, 2002). Studies evaluating environmental preferences 
of V. cholerae revealed that this bacterium is more often isolated from aquatic environments 
where salinity levels range between 0.2 % and 2 % and where temperature is greater than 17 oC 
(Nair et al, 2002). In aquatic surroundings, V. cholera is associated with various organisms 
including cyanobacteria, diatoms, filamentous green algae, oysters, water hyacinth, and volvox. 
(Nair et al, 2002). In humans, infection with V. cholera results in acute and potentially lethal 
diarrheal disease known as cholera. According to the World Health Organization (2014), there 
are approximately 3 to 5 million cases of cholera per year, and 100,000 to 200,000 of deaths 
result from these cases.  
 
 In general, cholera is transmitted through the oral route with ingestion of contaminated 
water or food. The dose of V. cholerae that can trigger the disease is about 103 to 108 of bacterial 
cells (Schmid-Hempel and Frank, 2007). Individuals who have low stomach acidity or an O-type 
of blood are more susceptible to develop cholera as a result of infection with pathogenic Vibrio 
species (Nalin D. R. et al, 1978; Harris J.B et al, 2005). After passage though acidic stomach 
environment, V. cholerae forms colonies on epithelium tissues of the small intestine. Afterwards, 
bacteria cells begin to produce cholera enterotoxin (CT), which upon release into extracellular 
environment of the small intestine, disrupts ion transport in the epithelial cells (Nair et al, 2002). 
This process results in loss of water and electrolytes, leading to characteristic symptoms of 
  
 
 
 
 
 
 
cholera. According to the World Health Organization (2014), several vaccines had been 
developed to prevent the spread cholera disease. However, since V. cholera species could evolve 
to become resistant to the vaccines, it is necessary to design medical treatments that would 
inhibit the growth of V. cholera colonies after infection has already occurred. Research studies 
focusing on the regulatory mechanisms of V. cholera cell cycle may open a bridge to the 
development of very potent chemical agents that are specific to Vibrio species and that could be 
used to effectively treat cholera disease. 
 
 Bacteria cell cycle is divided into three general stages that are indispensable for 
maintenance of genetic integrity of these organisms (Val et al, 2014). The first stage includes 
processes that occur in bacteria from the time of birth until chromosome replication initiation. 
Processes that mediate chromosome replication take place during the second stage of bacteria 
cell cycle. The third stage of bacteria cell cycle embraces events that happen during termination 
of DNA replication, chromosome segregation, and cell division, marking the end of the cell 
cycle. Genetic information in bacteria is commonly stored in a single circular chromosome. This 
type of genetic replicon has been extensively studied in E. coli (Robinson and van Oijen, 2013). 
Other types of genetic replicons exists in bacteria genomes and include plasmids, megaplasmids, 
and secondary chromosomes (Val et al, 2014). While replication of plasmids can take place 
several times per cell cycle, the replication of primary and secondary chromosomes, as well as 
megaplasmids, occurs only once per cell cycle  (Pinto et al, 2012; Val et al 2014).  
 
 Bacteria containing more than one chromosome can serve as strategic models to study 
molecular mechanisms that coordinate the replication of multipartite genomes in time and space. 
V. cholerae species are very suitable as models for such studies, since the genome of these 
bacteria is divided between two chromosomes (Trucksis et al, 1998). In V. cholerae, genetic 
information is disproportionately shared among primary chromosome I (chrI) and secondary 
chromosome II (chrII). ChrI contains 2.96 Mb, and chrII contains 1.07 Mb (Heidelberg et al, 
2000). Genes that are vital for cell survival, as well as genes that confer pathogenicity, are 
located on chrI. On the other hand, certain genes that are important for cellular transport and 
metabolism are found on chrII (Heidelberg et al, 2000). Studies focusing on the mechanisms of 
DNA replication in V. cholerae revealed that replication of chrI and chrII is synchronously 
coordinated (Rassmussen T. et al, 2007). Specifically, initiation of replication of chrI occurs 
before initiation of replication of chrII. When approximately 2/3 of chrI has been replicated, then 
the initiation of chrII replication commences (Val et al 2014). Consequently, termination of 
DNA replication and chromosome segregation occur simultaneously in chrI and chrII. 
 
 Generally, the initiation of DNA replication in bacteria commences when an initiator 
protein binds to a specific DNA sequence, referred to as the origin of replication. The binding of 
initiator protein to the origin is followed by unwinding of the DNA double helix and formation 
of the two replication forks (Zakrzewska-Czerwinska, 2007). In E. coli, the initiation of DNA 
replication begins after DnaA initiator protein binds to the DnaA boxes located within E. coli 
  
 
 
 
 
 
 
chromosome origin of replication, OriC (Robinson and van Oijen, 2013). Like OriC, V. cholerae 
origin of replication of chrI (OriCI) also contains DnaA box, and the replication of chrI is 
initiated with the binding of DnaA to OriCI (Val et al 2014). The replication of chrII is 
stimulated by a distinct mechanism. Although the origin of replication of chrII (OriCII) contains 
a DnaA box, a different initiator protein, called RctB induces chrII replication. Figure 1 
illustrates a schematic representation of OriCII and RctB binding sites. The sites to which RctB 
protein binds are known as 12-mer and 39-mer. While binding of RctB to 12-mer facilitates the 
initiation of chrII replication, the binding of RctB to 39-mer sequences inhibits chrII replication 
(Venkova-Canova et al, 2013). 
 
 All members of the Vibrionaceae family express RctB protein (Egan and Waldor, 2003; 
Yamaichi et al, 2009). However, no homologs of RctB were found outside of the Vibrionaceae 
family. Interestingly, rctB gene is positioned downstream of OriCII (Val et al 2014). In addition, 
OriCII region is flanked by another gene called rctA, which is located upstream of OriCII (Egan 
et al, 2006). Egan et al (2006) found that RctB binds within the region of its own promoter and 
represses the transcription of rctB. Researchers also discovered that RctB interacts with rctA 
promoter. The position of rctB in the proximity of OriCII and RctB autorepressory activity may 
be important aspects of the regulatory mechanism of chrII replication. Recently, Jha et al (2012) 
discovered that RctB monomers and dimers can interact with OriCII region. Specifically, 
researchers found that RctB was able to bind 12-mer sequences as a monomer or a dimer. 
According to Jha et al (2006), the binding of RctB to 12-mer sequences can facilitate the 
initiation of chrII replication. Additionally, researchers found that RctB in its dimeric form can 
bind to 39-mer sequences (Jha et al, 2012). The results of these studies suggest that RctB can 
play versatile roles in chrII maintenance.  
 
 
Figure 1. Illustration of OriCII region in chromosome II of V. cholerae. Green and magenta triangles 
represent 12-mer and 11-mer sequenced in their relative orientation. 39-mer sequences are shown as dark 
purple triangles. DnaA box is specified by a blue box. rctB and rctA genes are marked by gray and pink 
arrows, respectively. The relative transcription start site of each gene is marked by black arrows. The 
figure is not drawn to scale. (Egan et al, 2006). 
  
 
 
 
 
 
 
 Future structural studies of RctB will further elucidate the role of this protein in the 
mechanism of chrII replication in V. cholerae. Structures of RctB in its monomeric and dimeric 
forms could provide important insight on the processes that regulate RctB activity, whereas 
structures of RctB bound to DNA will help to decrypt the regulatory mechanism of chrII 
replication. Additionally, structural analysis of RctB will provide invaluable information for the 
design of Vibrio-specific antibacterial medications that could be used for cholera treatment. 
However, no structure of RctB has been solved. In this report, we describe the results of several 
experiments that were performed with four RctB constructs with an intention of producing 
protein crystals suitable for X-ray crystallography analysis of RctB structure.  
 
 To produce protein crystals for crystallographic studies of RctB, we used four RctB 
constructs that represented about 1/5th of the original amino acid sequence of RctB (Figure 2). 
The first of these constructs, termed RctB S2-L124-C-His, encompassed 130 amino acids of the 
N-terminus of wild type (wt) RctB starting from Ser-2 to Leu-124 with added His tag. The other 
three RctB constructs were mutant versions of RctB S2-L124-C-His. Specifically, RctB 
construct called RctB S2-L124-L20M-C-His included a substitution at position 20 of the amino 
acid sequence, replacing Leu-20 with Met, whereas RctB construct called RctB 
S2-L124-L48M-C-His contained identical substitution at position 48 of the amino acid sequence. 
The third mutant construct, RctB S2-L124-L20M-L48M-C-His, included equivalent substitutions 
at positions 20 and 48 of the amino acid sequence. The four RctB constructs were used during 
experiments that involved cell growths, protein purifications, and preparation of protein 
crystallization plates. In the following sections, we will describe the methods and the results of 
these experiments.  
 
 
Figure 2. Schematic representation of wild type RctB and four RctB constructs that were used for 
cell growth, protein purification, and protein crystallization experiments. 
  
 
 
 
 
 
 
Methods 
 
Cell Growth Experiments 
Transformation and growth of bacteria expressing RctB-S2-L124-C-His 
  E. coli cells of BL21 strain were transformed with pNO012 plasmid designed using 
parent pET24a plasmid to include DNA coding sequence for RctB-S2-L124-C-His. Specifically, 
100 µL of BL21 cells were transformed with 1 µL of pNO012 and were placed to incubate on ice 
for 20 minutes. After termination of the incubation period, the cells were heat shocked in a water 
bath at 42 oC for 30 seconds. Immediately after the heat shock, the cells were placed into ice to 
cool for 1 minute. Afterwards, 200 µL of LB media were added to the tube containing cells, and 
the resulting cell mixture was placed into a shaker to incubate at 37 oC and 250 rpm for 1 hour. 
Thereafter, the cell culture was transferred onto an agar plate that was supplemented with LB 
media and kanamycin (50 µg/mL). The plate was placed into an incubator set at 37 oC. 
 In the evening of the following day, a small scraping of 10 + bacteria colonies was taken 
from the agar plate, placed into a tube containing 1 mL of LB media, and resuspended with a 
micropipette. The ensuing cell suspension was added to a flask containing 200 mL of LB media 
and 200 µL of kanamycin. The flask was afterwards placed to incubate overnight into a shaker 
set at 37 oC and 250 rpm. In the morning of the following day, 100 mL of the cell culture were 
used to inoculate 2 L of LB media supplemented with 2 mL of kanamycin. Totally, two flasks 
with 2 L of cell culture were prepared. The flasks were placed into a shaker at 37 oC, 250 rpm. 
Approximately, every 30 minutes, 1 mL sample of cell culture was taken from each flask for 
OD600 measurements. 
 Beckman Coulter DU800 spectrophotometer was used to measure OD600 levels in the cell 
culture. Prior to the recordings, the instrument was calibrated using 1 mL of LB media. OD600 
was recorded at 600 nm wavelength. When measured OD600 of the cell culture increased to 
approximately 0.6, the flasks were placed into a tray with cool water, and the temperature in the 
shaker was changed to 16 oC. When the temperature in the shaker decreased to 22 oC, the cell 
culture was induced with 2.1 mL of 0.5 M isopropyl-beta-D-thiogalactopyranoside (IPTG). 
Afterwards, the flasks were transferred back into the shaker to incubate overnight. 
 The cells were harvested in the morning of the following day. A sample of 1 mL of cell 
culture was taken from each flask for OD600 measurements. Subsequently, the cell culture was 
distributed into bottles and centrifuged at 3,750 rpm for 20 minutes. The supernatant was 
discarded and the cell pellet was resuspended in the Resuspension Buffer (50 mM potassium 
  
 
 
 
 
 
 
phosphate (pH 8.0), 500 mM sodium chloride, 10 mM imidazole, 5 % (v/v) glycerol, 5 mM 
2-mercaptoethanol). A total volume of 5 mL of the Resuspension Buffer was added per 1 g of 
cells. To ensure even distribution of cells in the Resuspension Buffer, the bottles containing cell 
mixture were placed into a shaker at 4 oC for 20 minutes. Afterwards, the cells were distributed 
into 50-mL tubes and stored in a freezer at - 80 oC. 
 SDS-PAGE gel electrophoresis procedure was performed to assess the production of 
RctB-S2-L124-C-His, following the induction of cell culture with IPTG. The samples were 
prepared as follows. A sample of 100 µL of cell culture was taken from each flask before 
induction with IPTG and prior to harvesting. The samples were placed into Eppendorf tubes and 
were centrifuged for 1 minute at 14,000 rpm. The supernatant was discarded, and the resulting 
pellets were resuspended in 2 µL of Coomassie Solution (0.25 % (w/v) Coomassie Brilliant Blue 
R-250, 10 % (v/v) acetic acid (Glacial), 28.5% (v/v) ethanol). The samples were heated for 3 
minutes at 35 oC. Afterwards, 10 µL of each sample and 10 µL of standard Protein Marker were 
loaded and run on a 15 % SDS-PAGE gel for 40 minutes in Mini-PROTEAN Tetra Cell chamber 
using Power Pac Universal Power Supply (Bio-Rad). The gel was stained using Coomassie 
Solution and destained using Coomassie Destain (10 % (v/v) acetic acid (Glacial), 19 % (v/v) 
ethanol). 
Transformation and growth of bacteria cells expressing RctB-S2-L124-L20M-C-His with SeMet   
 To produce BL21 cells expressing RctB S2-L124-L20M-C-His, bacteria transformation 
procedure was performed similarly to the transformation of the cells expressing 
RctB-S2-L124-C-His. Briefly, 100 µL of BL21 cells were placed into an Eppendorf tube and 
transformed with 1 µL of pNO015 plasmid. The cells were incubated on ice for the period of 1 
hour and heat shocked in a water bath at 42 oC for 40 seconds. After the heat shock, the tube 
containing cells was placed on ice for 1 minute. Next, 100 µL of LB media were added into the 
tube, and the resulting cell mixture was placed into a shaker at 37 oC, 250 rpm to incubate for 1 
hour. Afterwards, the cells were plated on agar plates, containing LB media and supplemented 
with kanamycin (50 µg/mL). The plate was placed into the incubator at 37 oC overnight.  
  In the evening of the following day, approximately 20 + colonies from the plate were 
transferred into a 50 mL of LB media, containing 50 μL of kanamycin. The flask with inoculated 
media was placed overnight into the shaker at 37 oC, 250 rpm. In the morning of the next day, 
M9 media was prepared. To prepare M9 media, the following components were added to the 
base media (100 mL 10 X M9 salts solution and 880 mL of distilled water, autoclaved): 2.0 mL 
of 1 M magnesium sulfate, 0.1 mL of 1 M calcium chloride, 0.4 mL of 10 mg/mL Thiamine * 
HCl, 25.0 mL of 20 % glucose, and 1.0 mL of 50 mg/mL kanamycin. 10 X M9 salts solution (0.5 
M sodium phosphate dibasic (anhydrous), 0.2 M potassium phosphate monobasic, 0.1 M sodium 
  
 
 
 
 
 
 
chloride, 0.2 ammonium chloride) was prepared prior to the experiment.  
 Afterwards, flask containing M9 media was placed into the shaker set at 37 oC to 
pre-warm for 1 hour. During that time, the cell culture was transferred into a 50-mL tube and 
centrifuged for 12 minutes, at 25 oC and 3,750 rpm. The supernatant was discarded and the pellet 
was resuspended with sterile pipette in 15 mL of M9 media, which was previously set aside for 
that purpose. The cells were centrifuged one more time and the supernatant was discarded. 
Additional 15 mL of M9 media were added to the tube and the pellet was resuspended. The 
resulting cell mixture was added into the flask containing 1 L of M9 media and the cells were left 
to grow at 37 oC, 250 rpm. 
 When measured OD600 was 0.6344, 20 mL of amino acid mix (0.03 M L-Lysine*HCl, 
0.04 M L-Threonine, 0.03 M L-Phenylalanine, 0.02 M L-Leucine, 0.2 M L-Isoleucine, 0.2 M 
L-Valine) and 50 mg of SeMet powder were added into the flask containing cell culture. The 
cells were left in the shaker to grow for additional 15 minutes at 37 oC. Subsequently, the 
temperature was set for 25 oC. After 20 minutes, the temperature was changed to 18 oC. When 
the temperature in the shaker was 23 oC, the cells were induced with 0.5 M IPTG (1 mM final 
concentration). Upon induction with IPTG, OD600 was 0.7582. Following induction, the cells 
were left to grow overnight at 18 oC. Next day, the cells were harvested. A total of 23.85 g of 
cells was collected. The cells were resuspended in the Resuspension Buffer (500 mM sodium 
chloride, 10 mM imidazole, 50 mM potassium phosphate (pH 8.0), 5 % glycerol, 10 mM 
2-mercaptoethanol). Specifically, 10 mL of Resuspension Buffer were added per gram of cells. 
The cell mixture was distributed into 50-mL tubes and placed for storage at – 80 oC. 
Growth of bacteria cells expressing RctB-S2-L124-L48M-C-His with SeMet   
To produce RctB-S2-L124-L48M-C-His, 100 μL of BL21 cells were transformed with 1 
μL of pNO017 plasmid. The subsequent experimental procedures were as described for the 
growth of BL21 cells expressing RctB-S2-L124-L20M-C-His with some distinctions. At 
induction with 0.5 M IPTG, measured OD600 was 0.7108. Upon harvesting, a total of 23.69 g of 
cells were collected. The cells were resuspended in the Resuspension Buffer (10 mL of buffer/1 
g of cells). The cell mixture was dispersed into 50-mL tubes and stored at – 80 oC. 
Growth of bacteria cells expressing RctB-S2-L124-L20M-L48M-C-His with SeMet   
 Experimental procedures, pertaining to the growth of BL21 cells expressing 
RctB-S2-L124-L20M-L48M-C-His, were performed using the same protocol as described for the 
growth of BL21 cells expressing RctB-S2-L124-L20M-C-His. Briefly, 100 µL of BL21 cells 
were transformed with pNO020 plasmid. The cells were grown in M9 media supplemented with 
  
 
 
 
 
 
 
amino acid mix and SeMet, as described. Upon induction with IPTG, measured OD600 in the cell 
culture was 0.6721. After harvesting, a total of 9.17 g of cells was collected. The cells were 
resuspended in the Resuspension Buffer (10 mL/gram of cells) and distributed into 50-mL tubes. 
The tubes containing cell mixture were stored at – 80 oC. 
Protein Purification Experiments 
 All protein purifications experiments were performed at 4 oC or on ice, except if 
indicated otherwise. 
Purification of RctB S2-L124-C-His 
1. Cell Lysis 
Approximately 60 mL of BL21 cells, previously transformed with pNO012 plasmid, 
were placed into a beaker on ice. Phenylmethyl-sulfonyl fluoride (PMSF) was added to cells to 1 
mM concentration (using 100 mM PMSF solution in isopropyl alcohol). French Press instrument 
was washed with 70 % (v/v) ethanol and equilibrated with Lysis Buffer (50 mM potassium 
phosphate (pH 8.0), 500 mM sodium chloride). Cells were lysed five times by French Press at a 
pressure of 1500-2000 bar. Subsequently, cell lysate was centrifuged at 16,000 rpm for 30 
minutes. 
2. Nickel Column 
 About 60 mL of the cell supernatant were collected after centrifugation of the cell lysate. 
Cell supernatant was carefully transferred into a beaker and placed on ice. Nickel Column was 
washed with distilled water and filled with 18 mL of Nickel-NTA agarose beads suspension. 
Nickel beads were washed with 1 column volume (CV) of distilled water and 1 CV of Nickel 
Column Buffer A (50 mM potassium phosphate, 500 mM sodium chloride, 5 mM 
2-mercaptoethanol). While the column was closed, additional 20 mL of Nickel Column Buffer A 
were added into the Nickel beads. The resulting Nickel beads suspension was transferred into the 
beaker containing cell supernatant, and the resulting mixture was placed to incubate for the 
period of 45 minutes. Every 10 minutes, the mixture was slightly spun to guarantee even 
distribution of Nickel beads and efficient protein binding. Following incubation, the mixture was 
loaded onto the Nickel Column and the flow through solution was collected into a separate 
container. 
Afterwards, the column was washed with Wash Buffers 1-5 that were prepared by 
combining Nickel Column Buffer A and Nickel Column Buffer B (50 mM potassium phosphate 
  
 
 
 
 
 
 
(pH 8.0), 500 mM sodium chloride, 500 mM imidazole, 5 mM 2-mercaptoethanol) in various 
proportions to create specific concentrations of imidazole. The concentrations of imidazole in 
Wash Buffers 1, 2, 3, 4 and 5 were 0 mM, 20 mM, 20 mM, 20 mM, and 40 mM, respectively. 
The volume of each Wash Buffer was 50 mL. RctB-S2-L124-C-His protein was eluted with 
Elution Buffers 1-3 (50 mM potassium phosphate (pH 8.0), 500 mM sodium chloride, 500 mM 
imidazole, 5 mM 2-mercaptoethanol; 30 mL each). The results of the purification of RctB 
S2-L124-C-His with Nickel Column were evaluated with SDS-PAGE gel electrophoresis. 
Protein solution from the flow through of Elution Buffers 1-2 (E1 and E2) was pooled for the 
following protein purification procedure. 
3. Q and SP Columns 
Nickel Column pool (E1 and E2, 60 mL) was diluted five times with Q-SP Column 
Buffer A (20 mM Tris 7.4, 5% (v/v) glycerol, 5 mM 2-mercaptoethanol). Q and SP Columns 
were combined and treated as a single column for washing, equilibration, and protein loading 
procedures. Q and SP Columns were attached to AKTA FPLC and washed with Q-SP Column 
Buffer B (2 M sodium chloride, 20 mM Tris 7.4, 5% (v/v) glycerol, 5 mM 2-mercaptoethanol) 
for a total volume of 100 mL. Then, the columns were equilibrated with 5 % (v/v) Q-SP Column 
Buffer B for a total volume of 200 mL. Peristaltic pump was first washed with 0.5 M sodium 
hydroxide and then equilibrated with 5 % (v/v) Q-SP Column Buffer B. Subsequently, peristaltic 
pump was used to load diluted Nickel Column pool into the Q and SP Columns. Resulting flow 
through solution was collected into a flask. Additional 100 mL of 5% (v/v) Q-SP Column Buffer 
B were loaded into the Q and SP Columns to ensure that target protein will transfer from the Q 
Column into the SP Column.  
Subsequently, SP Column alone was reattached to the AKTA FPLC and the column 
fractions were collected automatically. The volume of each fraction was 8 mL. Two peaks were 
observed in AKTA FPLC computer evaluation of the purification of RctB S2-L124-C-His with 
SP Column. Fractions from the corresponding peaks were combined into two pools. For Pool # 1 
fractions B6, B5, B4, and B3 were pooled for a total volume of 32 mL, and for Pool # 2 fractions 
B1, C1, C2, and C3 were pooled for a total volume of 32 mL. Fraction B2 appeared on the 
boundary between the two peaks and was not included into the pools. 
4. Dialysis and Concentration 
 SP Column Pool # 1 and Pool # 2 were dialyzed separately in Dialysis Buffer (50 mM 
sodium chloride, 20 mM Tris 7.4, 5% (v/v) glycerol, 5 mM 2-mercaptoethanol; 4 L). MWCO 3.5 
kDa PC tubing was used as a container for each protein solution. After dialysis procedure, 
approximately 32 mL of protein solution were collected for SP Column Pool # 1, and 32 mL of 
  
 
 
 
 
 
 
protein solution were collected for SP Column Pool # 2. Two 5K MWCO concentrators were 
used to concentrate protein solution for SP Column Pool # 1 that was collected after dialysis 
procedure. Protein solution from SP Column Pool # 2 was spun for 10 minutes at a 3,750 rpm. 
Precipitate was observed in a pellet, and supernatant was further concentrated in a distinct 5K 
MWCO concentrator.   
 When protein concentration in SP Column Pool # 1 was about 20 mg/ml, the solution was 
placed into the Eppendorf tube and centrifuged at 14,000 rpm and 4 oC for 10 minutes. No 
precipitate was observed. Protein solution was then transferred into a fresh tube. For Pool # 1, 
approximately, 1.5 mL of protein solution were collected. A portion of this solution was divided 
into aliquots and used to set up crystallization plates. Remaining solution was divided into 
additional aliquots, frozen in liquid nitrogen, and stored at – 80 oC. For SP Column Pool # 2, 
about 3 mL of protein solution was collected. This protein solution was frozen in liquid nitrogen 
and stored at – 80 oC. 
Purification of RctB S2-L124-L20M-C-His 
1. Cell Lysis 
 To purify RctB S2-L124-L20M-C-His, 255 mL of BL21 cells, expressing pNO015, were 
transferred into a beaker and placed on ice. PMSF (100 mM in isopropyl alcohol) was added to 
cells (1mM final concentration). Resulting cell mixture was lysed five times by French Press 
instrument at a pressure of 20,000-25,000 psi. Prior to cell lysis, French Press instrument was 
washed with 70 % (v/v) ethanol and equilibrated with Lysis Buffer (50 mM potassium phosphate 
(pH 8), 500 mM sodium chloride, 10 mM 2-mercaptoethanol). Cell lysate was centrifuged for 30 
minutes, at 16,000 rpm and 4 oC. 
2. Nickel Column 
 The purification of RctB S2-L124-L20M-C-His using Nickel Column proceeded in a 
similar manner as purification of RctB S2-L124-C-His with notable distinctions. Specifically, 
250 mL of cell supernatant were collected after centrifugation of cell lysate. Furthermore, 20 mL 
of Nickel-NTA agarose beads suspension were used for the experiment to maximize protein 
yield. Nickel beads were washed first with distilled water and with Nickel Column Buffer A (50 
mM potassium phosphate (pH 8), 500 mM sodium chloride, 10 mM 2-mercaptoethanol). 
Notably, after 45-minutes of incubation, Nickel beads and supernatant mixture was centrifuged 
for 1 minute at 1,000 rpm in 50-mL tube. Resulting supernatant was removed and Nickel beads 
were resuspended in Nickel Column Buffer A. This mixture was used to load the Nickel column.  
  
 
 
 
 
 
 
 Nickel Column was washed with Wash Buffers 1-5 (W1-W5) and protein was eluted 
with Elution Buffers 1-3 (E1-E3). To prepare Wash Buffers and Elution Buffers, Nickel Column 
Buffers A and B (50 mM potassium phosphate (pH 8), 500 mM sodium chloride, 500 mM 
imidazole, 10 mM 2-mercaptoethanol) were combined in various proportions to create buffers 
with specified imidazole concentrations (0, 20, 20, 20, 20 mM for W1-W5 and 500 mM for 
E1-E). Based on results of SDS-PAGE gel electrophoresis analysis of the outcome of this protein 
purification procedure, protein solution from the flow through of Elution Buffers 1 and 2 was 
pooled (60 mL) for next experiment. 
3. Q and SP Columns 
 To purify RctB S2-L124-L20M-C-His after Nickel Column experiment, Q and SP 
Columns were used. Nickel Column pool (E1 and E2, 60 mL) was diluted five times with Q-SP 
Column Buffer A (20 mM Tris (pH 7.35), 5% (v/v) glycerol, 10 mM 2-mercaptoethanol). Q and 
SP Columns were combined and washed with 200 mL of Q-SP Column Buffer B (2 M sodium 
chloride, 20 mM Tris (pH 7.35), 5% (v/v) glycerol, 10 mM 2-mercaptoethanol) and equilibrated 
with 200 mL 5 % (v/v) Q-SP Column Buffer B. Peristaltic pump was washed with 0.5 M sodium 
hydroxide and then with 5 % (v/v) Q-SP Column Buffer B.   
 Diluted Nickel Colum pool was loaded with peristaltic pump into the Q and SP Columns, 
and flow through solution was collected separately. Additional 100 mL of 5% (v/v) Q-SP 
Column Buffer B were loaded with peristaltic pump onto the Q and SP Columns. Then, the SP 
Column was reattached to the AKTA FPLC, and the column fractions were collected. AKTA 
FPLC computer analysis of protein purification by SP Column indicated that protein eluted in 
two different peaks. The first peak appeared over fractions 20, 21, and 22, which were pooled 
(SP Column Pool #1). The second peak appeared over fractions 24, 25, and 26. These fractions 
were also pooled in a separate container (SP Column Pool # 2). 
4. Dialysis and Concentration 
 Protein solutions from SP Column Pool # 1 and SP Column Pool # 2 were dialyzed 
separately. MWCO 3.5 kDa PC tubing was used as a protein solution container for the dialysis 
procedure. SP Column Pool # 1 (20, 21, and 22; 24 mL) was divided in two parts of 
approximately 12 mL each. The first part of  SP Column Pool # 1 (SP Column Pool # 1a) was 
placed to dialyze in Dialysis Buffer A (150 mM sodium chloride, 20 mM Tris 7.35, 5% (v/v) 
glycerol, 10 mM 2-mercaptoethanol; 2 L), whereas the second part (SP Column Pool # 1b) was 
placed to dialyze in Dialysis Buffer B (500 mM sodium chloride, 20 mM Tris 7.35, 5% (v/v) 
glycerol, 10 mM 2-mercaptoethanol; 4 L). In addition, SP Column Pool # 2 was placed to 
dialyze in Dialysis Buffer B.  
  
 
 
 
 
 
 
 Dialysis procedure took place overnight, and the resulting protein solution was collected 
on the following day. Each pool was concentrated using 5K MWCO concentrators to a final 
volume of 0.3 mL for SP Column Pool # 1a, 0.3 mL for SP Column Pool # 1b, and 0.75 mL for 
SP Column Pool # 2. Protein solution was then transferred into Eppendorf tubes and centrifuged 
for 10 minutes at 12,000 rpm and 4 oC. Precipitate was observed in protein solution of SP 
Column Pool # 1a. Subsequently, protein solutions were transferred into fresh tubes and final 
protein concentration was measured using Beckman Coulter DU800 spectrophotometer.  
 Prior to setting up of the crystallization plates, RctB S2-L124-L20M-C-His solution was 
centrifuged one more time at 14,000 rpm and 4 oC for 10 minutes and transferred into fresh 
tubes. Then, protein solutions from SP Column Pool # 1a and SP Column Pool # 2b were used 
for crystallization experiment. Remaining protein solution was divided into aliquots of about 100 
μL each. All aliquots were frozen in liquid nitrogen and placed for storage at – 80 oC. 
Purification of RctB S2-L124-L48M-C-His 
1. Cell Lysis 
 Approximately 260 mL of cells, previously transformed with pNO017 plasmid and 
induced to express RctB S2-L124-L48M-C-His, were transferred into a beaker and placed on ice. 
100 mM PMSF solution in isopropyl alcohol was added to cells prior to lysis to 1 mM final 
concentration. French Press instrument was cleaned with 70 % (v/v) ethanol and equilibrated 
with Lysis Buffer (50 mM potassium phosphate (pH 8.0), 500 mM sodium chloride, 10 mM 
2-mercaptoethanol). Thereafter, cell mixture was lysed by French Press at a pressure of 
20,000-25,000 psi and centrifuged for 30 minutes at 16,000 rpm and 4 oC. 
2. Nickel Column 
 A total of 20 mL of Nickel-NTA agarose suspension was used for the experiment. Nickel 
beads were first washed with distilled water and then with about 40 mL of Nickel Column Buffer 
A (50 mM potassium phosphate (pH 8), 500 mM sodium chloride, 10 mM 2-mercaptoethanol). 
Approximately, 20 mL of Nickel beads suspension was added into the supernatant, and the 
resulting solution was set to incubate for a period of about 45 minutes. Afterwards, the solution 
was poured into the column and the flow through was collected. Subsequently, Nickel Column 
was washed with Wash Buffers 1-5, as described for purification of RctB S2-L124-L20M-C-His. 
The protein was eluted three times with Elution Buffers 1-3. Following SDS-PAGE gel 
electrophoresis analysis of RctB S2-L124-L48M-C-His purification using Nickel Column, 
protein solution from the flow through of Elution Buffer 1 (E1) was pooled for subsequent 
purification procedure. 
  
 
 
 
 
 
 
3. Q and SP Columns 
 Nickel Column pool (E1, 30 mL) was diluted five times with Q-SP Column Buffer A (20 
mM Tris (pH 7.4), 5% (v/v) glycerol, 10 mM 2-mercaptoethanol). Combined Q and SP Columns 
were attached to AKTA FPLC. Afterwards, the columns were washed with 100 mL of Q-SP 
Column Buffer B (2 M sodium chloride, 20 mM Tris pH (7.4), 5% (v/v) glycerol, 10 mM 
2-mercaptoethanol) and equilibrated with  200 mL of 5 % (v/v) Q-SP Column Buffer B. 
Peristaltic pump was washed with 0.5 M sodium hydroxide and  with 5 % (v/v) Q-SP Column 
Buffer B, and then used to load diluted Nickel Colum pool into the Q and SP Columns. Flow 
through solution was collected separately. To move protein from Q Column into SP Column, 100 
mL of 5% (v/v) Q-SP Column Buffer B were loaded into the Q and SP Columns. Subsequently, 
SP Column alone was reattached to the AKTA FPLC, and column fractions were collected. 
AKTA FPLC computer evaluation of protein purification by SP Column indicated that protein 
eluted in two peaks. The first peak appeared over fractions B5, B4, and B3, which were pooled 
(SP Pool #1). The second peak appeared over fractions B2, B1, and C1. These fractions were 
also pooled in a separate container (SP Column Pool # 2). 
4. Dialysis and Concentration 
 Protein dialysis took place overnight. MWCO 3.5 kDa PC tubing was used to hold 
protein solution during the procedure. SP Column Pool # 1 (B5-B3) was placed to dialyze in 2 L 
of Dialysis Buffer # 1 (150 mM sodium chloride, 20 mM Tris (pH 7.4), 5% (v/v) glycerol, 10 
mM 2-mercaptoethanol), whereas SP Column Pool # 2 was placed to dialyze in 2 L of Dialysis 
Buffer # 2 (500 mM sodium chloride, 20 mM Tris (pH 7.4), 5% (v/v) glycerol, 10 mM 
2-mercaptoethanol).  
 On the following day, protein solution was collected, and each pool was concentrated 
using 5K MWCO concentrators to the final volume of 1.2 mL for SP Column Pool # 1 and 0.6 
mL for SP Column Pool # 2. The resulting protein solution was transferred into Eppendorf tubes 
and centrifuged for 10 minutes at 14,000 rpm, 4 oC. Precipitate was observed in protein solution 
of SP Column Pool # 1 (sample of pellet was taken and analyzed with SDS-PAGE gel 
electrophoresis). Solution was transferred into fresh tubes and final protein concentration was 
measured. Collected protein solution was used to set up crystallization plates. Remaining protein 
solution was spun again for 10 minutes at 14,000 rpm, 4 oC and divided into aliquots of 100 μL 
each. All aliquots were frozen in liquid nitrogen and placed for storage at – 80 oC. 
Purification of RctB S2-L124-L20M-L48M-C-His 
1. Cell Lysis 
  
 
 
 
 
 
 
 To purify RctB S2-L124-L20M-L48M-C-His, 40 mL of BL21 cells, which were 
previously transformed with pNO020 plasmid, were used. The cells were placed into a beaker on 
ice. Prior to lysis, cells were diluted two times with Lysis Buffer (50 mM potassium phosphate 
(pH 8.0), 500 mM sodium chloride, 10 mM 2-mercaptoethanol). 100 mM solution of PMSF in 
isopropyl alcohol was added to the cell mixture to 1 mM final concentration. Thereafter, cells 
were lysed with French Press instrument at a pressure of 20,000-25,000 psi and centrifuged at 
16,000 rpm and 4 oC for 30 minutes. 
2. Nickel Column 
 The purification of RctB S2-L124-L20M-L48M-C-His using Nickel Column proceeded 
using similar protocol as described for previous protein purifications with noted distinctions. 
Briefly, 10 mL of Ni-NTA agarose beads suspension was used. Nickel beads were washed with 
distilled water and then with Nickel Column Buffer A. Subsequently, Nickel beads suspension 
was added to 90 mL of collected supernatant. The resulting mixture incubated for a period of 45 
minutes with periodic swirling. Afterwards, the mixture was poured into the Nickel Column, and 
the flow through solution was collected for analysis. Next, Wash Buffers 1-5 and Elution Buffers 
1-3 were poured into the column in a sequential manner and the flow through solutions were 
collected individually. SDS-PAGE gel electrophoresis analysis of the purification of RctB 
S2-L124-L20M-L48M-C-His indicated that target protein was present in the flow through from 
Elution Buffer 1. This solution was pooled and used for subsequent experiments.  
3. Q and SP Columns 
 Nickel Column pool (E1, 30 mL) was diluted five times with Q-SP Column Buffer A (20 
mM Tris ( pH 7.4), 5% (v/v) glycerol, 10 mM 2-mercaptoethanol) and purified using combined 
Q and SP Columns in conjunction with AKTA FPLC in an analogous manner as described for 
previous purifications using this method. Both columns were washed with 100 mL of Q-SP 
Column Buffer B (2 M sodium chloride, 20 mM Tris (pH 7.4), 5% (v/v) glycerol, 10 mM 
2-mercaptoethanol) and equilibrated with 200 mL of 5 % (v/v) Q-SP Column Buffer B. AKTA 
FPLC computer evaluation of the purification of RctB S2-L124-L20M-L48M-C-His revealed 
that protein solution eluted in a single peak. SDS-PAGE gel electrophoresis analysis confirmed 
the presence of target protein in fractions marked by the peak. Based on these analyses, fractions 
B4, B3, B2 were pooled for a total volume of 24 mL and dialyzed. 
4. Dialysis and Concentration 
 SP column pool was divided into two parts of about 12 mL each. Each part (from now on 
referred to as Pool # 1 and Pool # 2) was dialyzed in distinct buffers. Specifically, Pool # 1 was 
  
 
 
 
 
 
 
dialyzed in Dialysis Buffer 1 (150 mM sodium chloride, 20 mM Tris (pH 7.4), 5% (v/v) glycerol, 
10 mM 2-mercaptoethanol), and Pool # 2 was dialyzed in D ialysis Buffer # 2 (500 mM sodium 
chloride, 20 mM Tris 7.4, 5% glycerol, 10 mM 2-mercaptoethanol). MWCO 3.5 kDa PC tubing 
was used to construct containers to hold protein solution during dialysis. Protein solution was 
dialyzed overnight, and the resulting protein solution was collected on the following day.  
 Each pool was concentrated using 5K MWCO concentrators to the final volume of 0.300 
mL for Pool # 1 and 0.150 mL for Pool # 2. Protein solution was then transferred into Eppendorf 
tubes and centrifuged at 14,000 rpm and 4 oC for 10 minutes. Precipitate was observed as a 
pellet. Solution was transferred into fresh tubes and final protein concentration was measured. 
UV Spectroscopy Method was also used to determine protein concentration, but the results were 
not conclusive, possibly due to the presence of precipitate in the final protein solution. 
Consequently, final protein concentration was verified by Bradford Method. Prior the 
preparation of crystallization plates, protein solution was centrifuged once more, as described. 
Precipitate was also observed as a pellet. Clear protein solution was used to set up crystallization 
plates. 
SDS-PAGE Gel Electrophoresis Tests 
 Samples of protein solution were mixed with Coomassie Solution (0.25 % (w/v) 
Coomassie Brilliant Blue R-250, 10 % (v/v) acetic acid (Glacial), 28.5% (v/v) ethanol) in a 1:1 
ratio in Eppendorf tubes. 10 L of prepared samples were loaded on 15 % SDS-PAGE gels and 
run in Mini-PROTEAN Tetra System chamber (Bio-Rad) at 214 V for 40 minutes using 8X 
Running Buffer (200 mM Tris base, 2 M glycine, 0.1 % (w/v) SDS, pH 8.3). The gels were 
stained with Coomassie Solution for 5 minutes and destained with Coomassie Destain (10 % 
(v/v) acetic acid (Glacial), 19 % (v/v) for 5 or more minutes. 
Protein Concentration Measurements 
 Protein concentration measurements were made using Bradford Method or UV 
Spectroscopy Method. For concentration measurements involving Bradford Method, samples 
were prepared as follows. To prepare a “blank” sample, 960 L of distilled water and 240 L of 
Bradford Reagent were mixed in a cuvette and used to calibrate the instrument. To prepare 
experimental sample, 950 L of distilled water, 240 L of Bradford Reagent, and 10 L of 
protein solution sample were mixed in a cuvette. Using Bradford Method, absorbance of protein 
solution samples were measured at 595 nm wavelength. For protein concentration measurements 
involving UV Spectroscopy Method, a 100 L sample of dialysis buffer was used to calibrate 
spectrophotometer and to record “blank” measurement for reference. Absorbance of samples was 
  
 
 
 
 
 
 
recorded at 280 nm wavelength. Experimental samples were prepared by mixing 95 L of 
dialysis buffer with 5 L sample of protein solution. All absorbance readings were made using 
Beckman Coulter DU800 spectrophotometer.  
Protein Crystallization Experiments 
 All crystallization plates were set up at 4 oC using Art Robbins Gryphon Systems 
(Rigaku) and crystallization plates of Crystal Mation Intelli-plate 96-3 design (Rigaku). 
Crystallization plates that were prepared using RctB S2-L124-C-His were set up using both fresh 
and frozen protein samples. Crystallization plates that were prepared using fresh protein samples 
of RctB S2-L124-C-His were set up with commercial screens and optimized screens. 
Commercial screens used to set up fresh samples of RctB S2-L124-C-His included JCSG Plus 
and ProComplex (Qiagen), whereas optimized screens included DJ PEGS 2 150 NaCl, DJ PEGS 
3 150 NaCl, DJ PEGS2 100 AS, DJ PEGS 3 100 AS, 032214 NO Screen 7 Part 1, and 032214 
NO Screen 7 Part 2 (Dr. Jeruzalmi’s Laboratory). Additional crystallization plates were set up 
using frozen samples of RctB S2-L124-C-His. These plates were set up using commercial screen 
JCSG Plus (Qiagen) and optimized screen 14 071614 NO RN OPT1 (Dr. Jeruzalmi’s 
Laboratory).  
 Crystallization plates that were prepared using fresh samples of RctB 
S2-L124-L20M-C-His were set up using commercial screens JCSG Plus and JCSG Core II 
(Qiagen)  and an optimized screen 14 071614 NO RN OPT1. Both fresh and frozen samples of 
RctB S2-L124-L48M-C-His were used to prepare crystallization plates. To prepare 
crystallization plates with fresh samples of RctB S2-L124-L48M-C-His, JCSG Plus, JCSG Core 
II, and the optimized screen 14 071614 NO RN OPT1 were used. Crystallization plates that were 
prepared using frozen samples of RctB S2-L124-L48M-C-His were made with ProComplex, 
PEGS, Compass, Classics, Classics Light, and PACT screens (Qiagen). Crystallization plates for 
RctB S2-L124-L20M-L48M-C-His were prepared using fresh samples of protein and JCSG Plus 
and JCSG Core II screens, and the optimized screen 14 071614 NO RN OPT1. 
Results and Discussion 
Results of the Cell Growth Experiments 
BL21 cells transformed with pNO012 expressed RctB S2-L124-C-His after induction with IPTG 
 To produce RctB S2-L124-C-His protein, we transformed BL21 cells with pN012 
plasmid and carried cell growth experiment using LB media. OD600 measurements were taken to 
determine the progress of cell growth. The summary of the results OD600 measurements made 
  
 
 
 
 
 
 
before and after induction with IPTG is provided in Table 1. As shown in Table 1, one hour after 
inoculation, the average OD600 in both flasks was 0.3547. Two hours after inoculation, the cell 
culture attained an average OD600 of 0.6156, which was close to the target OD600 value of 0.6. To 
evaluate the progress of cell growth after induction with IPTG, we measured OD600 before 
harvesting cells. Cell samples taken before the harvesting had an average OD600 of 1.0458, 
indicating that cells continued to divide after induction with IPTG.  
 
Figure 3. 15 % SDS-PAGE gel electrophoresis analysis of the cell growth experiment of BL21 cells 
expressing RctB S2-L124-C-His. Lane “M” represents sample of protein marker. Lanes labeled “Pre-1” 
and “Pre-2” mark samples taken before induction with IPTG from the first flask (OD600 = 0.6247) and the 
second flask (OD600 = 0.6065), respectively. “Post-1” and “Post-2” specify samples taken from the first 
flask (OD600 = 1.0628) and the second flask (OD600 = 1.0288) after induction with IPTG.  
  
 
 
 
 
 
 
Table 1. OD600 measurements of the cell growth experiment using BL21 cells that were transformed 
with pNO012. 
Sample ID OD600 at the 
pre-induction  
stage (1 h after 
inoculation) 
OD600 at the 
pre-induction stage 
(2 h after 
inoculation) 
OD600 at the 
post-induction stage 
(before harvesting) 
Blank (LB media) 0.0003 0.0003 0.0002 
Flask 1 0.3456 0.6247 1.0628 
Flask 2 0.3638 0.6065 1.0288 
 
 Figure 3 illustrates the results of SDS-PAGE gel electrophoresis analysis of the cell 
culture samples taken before and after induction. Evaluation of the SDS-PAGE gel revealed that 
cells expressed RctB S2-L124-C-His after induction with IPTG. In Figure 1, in lanes “Post-1” 
and “Post-2,” containing samples of cell culture taken after induction with IPTG, thick bands 
appeared of the size of about 14.3 kDa. These bands are absent in lanes “Pre-1” and “Pre-2,” 
which contained samples of cell culture taken before induction with IPTG. Taken together, the 
results of SDS-PAGE gel electrophoresis analysis suggest that BL21 cells, transformed with 
pNO012 plasmid, were able to produce RctB S2-L124-C-His after induction with IPTG. 
BL21 cells that were transformed with pNO015 and grown in M9 media containing SeMet were 
able to produce RctB S2-L124-L20M-C-His after induction with IPTG 
 To generate RctB S2-L124-L20M-C-His labeled with selenium, we transformed BL21 
cells with pNO015 plasmid that contained a sequence for the mutant version of the RctB 
S2-L124-C-His. This protein was designed to contain a methionine instead of leucine at position 
20 of the amino acid sequence. The cell culture was grown in M9 media supplemented with 
amino acid mix and SeMet. To monitor the progress of cell growth, OD600 measurements were 
taken during the course of the experiment. Table 2 provides a summary of OD600 measurements 
made at specific stages of cell growth. At inoculation of the M9 media, the OD600 was 0.1527. 
Amino acid mix and SeMet powder were added into the cell culture when OD600 was 0.6344. At 
induction with IPTG, OD600 was 0.7582. When cells were harvested, OD600 measurement was 
made once more and the results was 1.2836. 
 
  
 
 
 
 
 
 
 
Figure 4. 15 % SDS-PAGE gel electrophoresis analysis of the results of cell growth experiment 
using BL21 cells that were transformed with pNO015 plasmid. Lane “M” specifies protein marker. 
Lanes “1” and “2” denote samples of cells taken at inoculation (OD600 = 0.1527) and before addition of 
amino acid mix and SeMet (OD600 = 0.6344), respectively. Sample of cells taken at induction with IPTG 
(OD600 = 0.7582) is shown in lane “3.” Lane “4” specifies a sample of cells taken before harvesting 
(OD600 = 1.2836). Sample in lane “4” was diluted 3 times with M9 media to minimize viscosity of the 
original sample.  
  
 
 
 
 
 
 
Table 2. Summary of OD600 measurements made during the cell growth experiment using BL21 
cells that were transformed with pNO015. 
Sample ID OD600 
Blank 0.0003 
Inoculation 0.1527 
Before addition of AA mix and SeMet 0.6344 
At induction with IPTG 0.7582 
Before harvesting 1.2836 
 
 Using SDS-PAGE gel electrophoresis, we analyzed the samples taken at specific stages 
of the cell growth experiment to determine whether the cells were able to produce RctB 
S2-L124-L20M-C-His after induction with IPTG. As shown in Figure 4, BL21 cells expressed 
RctB S2-L124 C-His after induction with IPTG. In lane “4” a thin band is visible of the size of 
14.3 kDa in comparison to lanes “1,” “2,” and “3,” which contain samples of cell culture taken at 
inoculation, addition of amino acid mix and SeMet, and at induction with IPTG. Notably, sample 
in lane “4” was diluted 3 times to minimize the viscosity and to make the loading of the sample 
onto the gel more feasible. Collectively, the results of SDS-PAGE gel electrophoresis analysis of 
the cell growth experiment involving BL21 cells that were transformed with pNO015 plasmid 
imply that the cells produced RctB S2-L124-L20M-C-His after induction with IPTG. 
Upon induction with IPTG, BL21 cells that were transformed with pNO017 and grown in M9 
media containing SeMet expressed RctB S2-L124-L48M-C-His  
 To create cells expressing RctB S2-L124-L48M-C-His, we transformed BL21 cells with 
pNO017 plasmid that included coding sequence for this truncated version of RctB containing 
L48M substitution. The cells were grown in M9 media with the presence of SeMet to ensure 
incorporation of SeMet into the protein. The progress of cell growth experiment was monitored 
by periodic measurements of OD600. Table 3 provides a summary of the OD600 measurements 
that were made at specific stages of the experiment. Sample of M9 media was used to calibrate 
spectrophotometer. At inoculation of the M9 media, OD600 was 0.1437. When OD600 was 0.5869, 
amino acid mix and SeMet were added to the cell culture. At induction with IPTG, OD600 was 
0.7108. Before harvesting of the cells, OD600 was 1.1243, indicating that addition of IPTG did 
not inhibit cell division.  
  
 
 
 
 
 
 
 
Figure 5. SDS-PAGE gel electrophoresis analysis of the results of cell growth experiment using 
BL21 cells that were transformed with pNO017 plasmid. Lane “M” indicates protein marker. Lanes 
“1” and “2” denote samples of cells taken at inoculation (OD600 = 0.1437) and before addition of amino 
acid mix and SeMet (OD600 = 0.5869), respectively. Sample of cells taken at induction with IPTG (OD600 
= 0.7108) is shown in lane “3.” Lane “4” represents a sample of cells taken before harvesting (OD600 = 
1.1243). Sample in lane “4” was diluted 3 times with M9 media.  
  
 
 
 
 
 
 
Table 3. Summary of OD600 measurements made during the cell growth experiment using BL21 
cells that were transformed with pNO017. 
Sample ID OD600 
Blank 0.0003 
Inoculation 0.1437 
Before addition of AA mix and SeMet 0.5869 
At induction with IPTG 0.7108 
Before harvesting 1.1243 
 
 To determine whether the production of RctB S2-L124-L48M was stimulated upon 
induction with IPTG, we analyzed samples of cell culture using SDS-PAGE gel electrophoresis. 
Figure 5 features the results of SDS-PAGE gel electrophoresis analysis of the cell culture 
samples that were taken during the course of the cell growth experiment. A band of 
approximately 14.3 kDa size, marking RctB S2-L124-L48M-C-His, was detected on the gel in 
lane “4,” which contained a sample of cell culture taken before harvesting. Unlike samples in 
lanes “1,” “2,” and “3,” sample in lane “4” was diluted 3 times with M9 media. Thus, even 
though band marking RctB-S2-L124-L48M-C-His appeared to be thin on the gel, we concluded 
that after induction with IPTG, BL21 cells that were transformed with pNO017 plasmid 
produced target protein. 
Following induction with IPTG, BL21 cells that were transformed with pNO020 and grown in 
M9 media containing SeMet expressed RctB S2-L124-L20M-L48M-C-His  
 RctB S2-L124-L20M-L48M-His was produced by transforming BL21 cells with pNO020 
plasmid and growing cell culture in M9 media, complemented with amino acid mix and SeMet. 
During the cell growth experiment, we evaluated the amount of cells in the cell culture by 
measuring OD600. Table 4 lists a summary of OD600 measurements made at specific stages of cell 
growth experiment including inoculation of M9 media, addition of amino acid mix and SeMet, 
induction with IPTG, and harvesting. As shown in Table, OD600 progressively increased during 
the course of experiment, indicating that cells continued to reproduce after induction with IPTG.  
  
 
 
 
 
 
 
 
Figure 6. SDS-PAGE gel electrophoresis analysis of the results of cell growth experiment using 
BL21 cells that were transformed with pNO020 plasmid. Lane “M” indicates protein marker. Lanes 
“1” and “2” denote samples of cells taken at inoculation (OD600 = 0.1351) and before addition of amino 
acid mix and SeMet (OD600 = 0.5396), respectively. Sample of cells taken at induction with IPTG (OD600 
= 0.6721) is shown in lane “3.” Lane “4” represents a sample of cells taken before harvesting (OD600 = 
1.1669). Sample in lane “4” was diluted 3 times with M9 media.  
 
  
 
 
 
 
 
 
Table 4. Summary of OD600 measurements made during the cell growth experiment using BL21 
cells that were transformed with pNO020. 
Sample ID OD600 
Blank 0.0003 
Inoculation 0.1351 
Before addition of AA mix and SeMet 0.5396 
At induction with IPTG 0.6721 
Before harvesting 1.1669 
 
 The production of RctB S2-L124-L20M-L48M was verified using SDS-PAGE gel 
electrophoresis. We predicted that BL21 cells will express RctB S2-L124-L20M-L48M-C-His 
after induction with IPTG. Figure 6 shows the results of SDS-PAGE gel electrophoresis analysis 
of the cell growth experiment. As expected, a band of 14.3 kDa size, specifying RctB 
S2-L124-L20M-L48M, was present in lane “4,” which contained a sample of cell culture taken 
before harvesting of the cells. These results confirmed our former expectations. 
Results of the Protein Purification Experiments 
Analysis of the purification of RctB S2-L124-C-His indicated that protein bound to Nickel beads 
and eluted at 500 mM of imidazole 
 To isolate RctB S2-L124-C-His from crude cell extract that was obtained after 
centrifuging cell lysate of the BL21 cells, Nickel Column was used. Since RctB-S2-L124-C-His 
construct was designed to contain a His tag at the C-terminus, we expected that the protein will 
bind Nickel beads. To elute protein from the column, 500 mM imidazole Elution Buffers 1-3 
were prepared and used during purification procedure. Prior to eluting protein, we used Wash 
Buffers 1-5, with increasing concentrations of imidazole, to wash the Nickel Column and to 
remove any contaminant protein. Subsequently, SDS-PAGE gel electrophoresis was performed 
to evaluate the results of purification of RctB S2-L124-C-His using Nickel Column (Figure 7). 
 In addition to samples of the flow through solutions obtained after pouring Wash Buffers 
and Elution Buffers into the column, we also analyzed samples of cell pellet and cell supernatant 
to determine how much RctB S2-L124-C-His was lost in the cell pellet and how much of it was 
  
 
 
 
 
 
 
recovered in the supernatant. Additionally, we analyzed a sample of initial flow through to check 
whether the protein was able to bind to the Nickel beads. As shown in Figure 7, bands of about 
14.3 kDa were present in lanes “P” and “S,” indicating that while some protein was lost in the 
cell pellet, a significant amount was recovered in the cell supernatant. A very negligible amount 
of protein may have been lost in the initial flow through, confirming our expectation that RctB 
S2-L124-C-His was able to bind to the Nickel beads. Most protein eluted at 500 mM imidazole 
(lanes “E1” and “E2” in Figure 7). However, some RctB S2-L124-C-His eluted at 40 mM 
imidazole (lane “W5”).    
 
Figure 7. SDS-PAGE gel electrophoresis analysis of the purification of RctB S2-L124-C-His using 
Nickel Column. Lane "M" specifies protein marker. Lanes "P," "S," and "FT" indicate samples of cell 
pellet, cell supernatant, and initial column flow through solution, respectively. Samples taken from the 
flow through solution after Wash Buffers 1,2,3,4,  and 5 and Elution Buffers 1,2, and 3 were poured into 
the column are represented in lanes "W1," "W2," "W3," "W4," and "W5" and "E1," "E2," and "E3," 
accordingly. Imidazole concentrations in Wash Buffers 1-5 were 0, 20, 20, 20, and 40 mM and the total 
volume of each buffer was 50 mL. The volume of Elution Buffers 1-3 was 30 mL, each with 500 mM 
imidazole concentration. Each lane contained 10 L of protein solution sample. All samples were run on 
15 % SDS-PAGE gel and stained with Coomassie Solution.  
  
 
 
 
 
 
 
 To estimate the initial protein concentration and the net amount of RctB S2-L124-C-His 
obtained after purification of the protein with Nickel Column, we measured absorbance of the 
samples of protein solutions using Bradford Method. At 595 nm wavelength, the absorbance of a 
sample of cell supernatant was 0.4081, and the absorbance of a sample of Nickel Column pool 
was 0.1828. Using the dilution factor of 10 and the protein extinction coefficient of 0.476, we 
estimated that protein concentration in the cell supernatant was 8.57 mg/mL, and the calculated 
amount of protein was 514.41 mg. Comparative calculations were made for a sample of Nickel 
Column pool. The concentration of protein in Nickel Column pool was 3.84 mg/mL with a net 
amount of 230.42 mg of protein. The summary of protein concentration measurements using 
Bradford Method is provided in Table 5. 
Purification of RctB S2-L124-C-His with Q and SP column produced two different protein pools 
 To further purify RctB S2-L124-C-His solution collected after purification procedure 
involving Nickel Column, we used AKTA FPLC protein purification system and a combination 
of Q and SP columns. As shown in Figure 8, AKTA FPLC computer evaluation of the 
purification of RctB S2-L124-C-His using SP Column revealed that protein solution eluted in 
two distinct peaks. The first peak appeared over fractions B6, B5, B4, and B3, and the second 
peak appeared over fractions B1, C1, C2, and C3.  Furthermore, fraction B2 marked the 
boundary between the peaks (Note: The specific order of the fractions was determined with the 
"serpentine" pattern by means of which AKTA FPLC was programmed to collect fractions.) 
 To further analyze the results of the purification of RctB S2-L124-C-His using Q and SP 
Columns, we performed SDS-PAGE gel electrophoresis to examine SP Column fractions for the 
presence of target protein. Since AKTA FPLC computer evaluation of the purification of RctB 
S2-L124-C-His with SP Column revealed that protein eluted in two peaks, we expected that 
these results will be reflected in the SDS-PAGE gel electrophoresis analysis of the samples taken 
from the fractions marked by two peaks. We hypothesized that additional bands might have 
appeared on the gel in the samples taken from fractions associated with either of the two peaks. 
However, contrary to our expectations, no additional bands appeared. As shown in Figure 9, 
lanes containing samples of fractions B6, B5, B4, and B3, marked by the first peak, and fractions 
B1, C1, C2, and C3, marked by the second peak, each appeared to feature a single band of about 
14.3 kDa in size. Lane that contained a sample from fraction B2, which represented the boundary 
of the two peaks, also exhibited this band.  
 The results of SDS-PAGE gel electrophoresis analysis of the purification of 
RctB-S2-L124-C-His implied that most protein eluted in the fractions B6-B1 and C1-C3. 
Intrigued by these results, we decided to pool fractions marked by different peaks into different 
pools and treat each pool separately to determine whether further analysis of the protein solutions 
  
 
 
 
 
 
 
will reveal any discrepancies. Thus, we pooled fractions B6, B5, B4, and B1 into Pool #1 and 
fractions B1, C1, C2 and C3 into Pool # 2. Fraction B2 was omitted from either pool, since it 
was positioned on the boundary of the two peaks and was likely to contain a mixture of proteins, 
provided that the two peaks represented distinct protein populations. 
 To evaluate protein yield after purification of RctB S2-L124-C-His, we measured protein 
concentration using Bradford Method. At 595 nm wavelength the absorbance of Pool # 1 was 
0.7262, whereas the absorbance of Pool # 2 was 0.7736. With protein extinction coefficient of 
0.476, the estimated protein concentration in Pool # 1 was 1.53 mg/mL and 1.63 mg/mL in Pool 
#2. The total protein yield in Pool # 1 was 48.8 mg, whereas in Pool # 2 the total protein yield 
was 52.0 mg (refer to Table 5 for further details).  
 
Figure 8. AKTA FPLC computer evaluation of the purification of RctB S2-L124-C-His using SP 
column. The amount of protein eluted from the SP column is represented by blue line. Solution 
conductivity is indicated by brown line. Column fractions are marked on the bottom of the graph. Protein 
solution eluted in two peaks. The first peak appeared in fractions B6, B5 B4, and B3, whereas the second 
peak appeared in fractions B1, C1, C2, and C3. Fraction B2 marked the boundary between two peaks. 
  
 
 
 
 
 
 
  
Figure 9. Results of SDS-PAGE gel electrophoresis analysis of the purification of RctB 
S2-L124-C-His using Q and SP Columns. Lane "M" denotes protein marker. (Top panel) Lanes "L" and 
"FT" specify samples taken from the column load solution and the column flow through solution. Lanes 
"B8" through "B1" indicate samples taken from fractions B8 through B1. Lanes "C1" through "C4" 
specify samples taken from fractions C1 through C4. (Bottom panel) Additional gel was run to analyze 
additional samples. Thus, samples taken from fractions A5 though A7 are represented in lanes "A5" - 
"A7." Lanes "C5"-"C12," F3," and "F4" represent samples taken from fractions C5-C12, F3, and F4, 
respectively. All samples (10 L) were run on 15 % SDS-PAGE gels. Both gels were stained with 
Coomassie Solution. 
  
 
 
 
 
 
 
RctB S2-L124-C-His pools exhibited distinct properties after dialysis and concentration   
 
Figure 10. SDS-PAGE gel electrophoresis analysis of RctB S2-L124-C-His protein solutions before 
and after dialysis. Lane "M" represents protein marker. Lanes "P1-prD" and "P2-prD" specify 
pre-dialysis protein samples taken from Pool #1 and Pool # 2, respectively. Lanes "P1-poD" and 
"P2-poD" specify post-dialysis protein samples taken from Pool #1 and Pool # 2. Samples of pellet and 
supernatant formed after Pool # 2 was centrifuged for 10 minutes are shown in lanes "P2-P" and "P2-S," 
accordingly. Lane "P1-F" represents 10 times diluted sample of final protein product from Pool #1. Each 
lane contained 10 L sample of protein solution. Samples were run of 15 % SDS-PAGE gel. Coomassie 
Solution was used to stain the gel.    
  
 
 
 
 
 
 
 Two different RctB S2-L124-C-His pools, obtained after purification of this protein with 
SP Column, were dialyzed and concentrated under similar conditions. While protein solution of 
Pool # 1 collected after dialysis concentrated feasibly, protein solution of Pool # 2 concentrated 
rather slowly. Furthermore, white floating specks were observed in Pool # 2 after several rounds 
of concentration. We predicted that problematic concentration of Pool # 2 was a result of protein 
precipitation. To confirm the presence of precipitate in Pool # 2, we centrifuged protein solution 
for 10 minutes at 3,750 rpm. A pellet was observed in the tube after centrifugation procedure. 
Clean protein solution was further concentrated without delays. 
Table 5. Summary of protein concentration measurements made during the purification of RctB 
S2-L124-C-His.  Absorbance of protein solution was measured at 595 nm wavelength with Bradford 
Method. Protein concentration was calculated using dilution factor and protein extinction coefficient of 
0.476. 
Solution 
ID 
Volume 
(mL) 
Absorbance 
at 595 nm 
Dilution 
Factor 
Concentration 
(mg/mL) 
Amount 
(mg) 
Blank - 0.0008 - - - 
Cell 
Supernatant 
60 0.4081 10 8.57 514.41 
Nickel 
Column 
Pool (E1, 
E2) 
60 0.1828 10 3.84 230.42 
SP Column 
Pool # 1 
32 0.7262 1 1.53 48.82 
SP Column 
Pool # 2 
32 0.7736 1 1.63 52.00 
Pool # 1 
after 
Dialysis 
32 0.7162 1 1.50 48.15 
Pool # 2 
after 
Dialysis 
32 0.6110 1 1.28 41.08 
  
 
 
 
 
 
 
 Samples of protein solution from Pool # 1 and Pool # 2 were taken before and after 
dialysis and analyzed with SDS-PAGE gel electrophoresis. In addition, a sample of pellet and a 
sample of solution supernatant that were obtained after Pool # 2 was centrifuged were taken for 
evaluation. The results of SDS-PAGE gel electrophoresis analysis of Pool # 1 and Pool # 2 are 
represented in Figure 10.  A band of 14.3 kDa in size was present in lanes representing samples 
of Pool # 1 and Pool # 2 taken before and after dialysis. Similar band also appeared in lanes 
containing samples of pellet and supernatant, which were collected after Pool #2 solution was 
centrifuged. Significantly, no additional bands appeared on the gel, demonstrating that during the 
purification of RctB S2-L124-C-His nearly all contaminant proteins were removed. The absence 
of additional bands in lanes "P2-P" and "P-2S" also indicates that formation of protein precipitate 
did not occur as a result of protein degradation. 
Table 6. Protein concentration measurements of final protein product obtained after purification of 
RctB S2-L124-C-His. Absorbance of protein solution was recorded at 280 nm wavelength with UV 
Spectroscopy Method. Protein concentration was calculated using dilution factor and protein extinction 
coefficient of 0.476. 
Solution 
ID 
Volume 
(mL) 
Absorbance 
at 280 nm 
Dilution 
Factor 
Concentration 
(mg/mL) 
Amount 
(mg) 
Blank - 0.0008 - - - 
Pool # 1 
Final 
Product 
1.5 0.5329 20 22.39 33.6 
Pool # 2 
Final 
Product 
3.0 0.2630 20 11.05 33.2 
 To monitor protein concentration, samples of protein solution were taken and absorbance 
was recorded using both Bradford Method and UV Spectroscopy Method. After dialysis, the 
absorbance at 595 nm wavelength of a sample of protein solution from Pool # 1 was 0.7162, 
whereas the absorbance a sample of protein solution from Pool # 2 was 0.6110. Thus, the 
calculated protein concentration immediately after dialysis was 1.50 mg/mL in Pool # 1 and 1.28 
mg/mL in Pool # 2. Protein solution was concentrated until the final volume of 1.5 mL for Pool # 
1 and 3.0 mL for Pool # 2. At 280 nm wavelength, the absorbance of final protein solution from 
Pool # 1 was 0.5329, whereas the absorbance of final protein solution from Pool # 2 was 0.2630, 
as illustrated in Graph 1 and Graph 2, respectively. The net amount of protein obtained was 33.6 
mg for Pool #1 and 33.2 mg for Pool # 2. Summary of protein concentration measurements is 
  
 
 
 
 
 
 
provided in Table 5 and Table 6.  
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Graph 1. Absorbance of RctB S2-L124-C-His protein solution from Pool # 1 at a concentration of 
22.39 mg/mL 
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Graph 2. Absorbance of RctB S2-L124-C-His protein solution from Pool # 2 at a concentration of 
11.05 mg/mL. 
  
 
 
 
 
 
 
Analysis of the purification of RctB S2-L124-L20M-C-His with Nickel Column indicated that this 
RctB construct was able to bind Nickel beads and eluted at 500 mM imidazole  
 
Figure 11. Results of SDS-PAGE gel electrophoresis analysis of the purification of RctB 
S2-L124-L20M-C-His using Nickel Column. Lane "PM" indicates protein marker. Lanes "CP" and 
"CS" specify samples of cell pellet and cell supernatant, respectively. Lane "NS" represents a sample 
taken from the supernatant after 1-minute spin at 1,000 rpm of Nickel beads and cell supernatant mixture. 
Sample of initial column flow through is featured in lane "FT." Lanes "W1" -"W5" represent samples of 
the flow through solutions collected after Wash Buffers 1-5 were poured into the column. Similarly, lanes 
"E1," "E2," and "E3" specify samples of the flow through solution collected after Elution Buffers 1-3 
were poured into the column. All samples were run on 15% SDS-PAGE gel and stained with Coomassie 
Solution. Each well contained 10 L sample of protein solution. 
 To purify cell supernatant acquired from centrifuged lysate of BL21 cells that expressed a 
mutant version of RctB S2-L124-C-His and included L20M substitution (RctB 
S2-L124-L20M-C-His) we used Nickel Column. We expected that this new protein construct, in 
  
 
 
 
 
 
 
spite of containing a L20M substitution and SeMet, will bind to Nickel beads, since it also 
contained a His tag at the C-terminus. To increase the speed of purification, we centrifuged 
Nickel beads and cell supernatant after incubation (see Methods section for further details). 
Samples of cell pellet, cell supernatant, "Nickel supernatant," initial column flow through, as 
well as samples of the flow through solutions from Wash Buffers 1-5 and Elution Buffers 1-3, 
were taken and analyzed on 15 % SDS-PAGE gel.  
 The results of the SDS-PAGE gel electrophoresis analysis for the purification of RctB 
S2-L124-L20M-C-His are presented in Figure 11. Noticeable band of 14.3 kDa was detected in 
lanes "CP," "CS," "E1," and "E2," indicating that, although some amount of RctB 
S2-L124-L20M-C-His was lost in the cell pellet, a significant amount was recovered in the cell 
supernatant and eluted at 500 mM imidazole in the flow through from Elution Buffers 1 and 2. 
Faint band, marking RctB S2-L124-L20M-C-His, was also present in lane "W5," implying that 
small amount of target protein eluted at 40 mM imidazole. No clearly visible bands, specifying 
RctB S2-L124-L20M-C-His, were detected in lanes "NS" and "FT," suggesting that little or no 
protein was lost in the “Nickel supernatant” and column flow through solutions. Collectively, 
these results indicate that most RctB S2-L124-L20M-C-His protein bound to Nickel beads and 
eluted from the Nickel Column at 500 mM imidazole. 
 To evaluate the net amount of RctB S2-L124-L20M-C-His, present initially in the cell 
supernatant and obtained from purification procedures involving Nickel Column, we measured 
absorbance at 595 nm wavelength of samples of protein solution from cell supernatant and 
Nickel Column pool (E1 and E2, 60 mL) by means of Bradford Method. At 595 nm wavelength, 
the absorbance of a sample of cell supernatant was 0.1400 (dilution factor = 5), and the 
absorbance of Nickel Column pool was 0.7718 (dilution factor = 1). Using protein extinction 
coefficient of 0.476, we estimated that the amount of protein present in the cell supernatant was 
376.6 mg, whereas the amount of protein present in the Nickel Column pool was 97.3 mg. Table 
7 provides a synopsis of the concentration measurements performed at specific stages of RctB 
S2-L124-L20M-C-His protein purification experiment. 
Purification of RctB S2-L124-L20-M-C-His using Q and SP Columns produced two different 
protein populations. 
 Using Q and SP Columns we purified RctB S2-L124-L20M-C-His solution that was 
collected after purification of this protein construct with Nickel Column. AKTA FPLC computer 
evaluation of the purification of RctB S2-L124-L20M-C-His with SP Column revealed that 
protein eluted in two peaks in a similar manner as original RctB S2-L124-C-His construct 
(compare Figures 8 and 12). The first peak appeared over fractions 19, 20, 21, and 22, whereas 
the second peak appeared over fractions 24, 25, 26, and 27. Fraction 23 appeared on the 
  
 
 
 
 
 
 
boundary between two peaks. Samples from select fractions were examined with SDS-PAGE gel 
electrophoresis to validate the presence of protein in the fractions marked by the two peaks. 
 
Figure 12. AKTA FPLC computer evaluation of the purification of RctB S2-L124-L20M-C-His 
using Q and SP Columns. The amount of protein eluted from the SP Column is represented with a blue 
line. Solution conductivity is indicated with a brown line. Column fractions are marked on the bottom of 
the graph. As shown on the graph, RctB S2-L124-L20M-C-His eluted in two peaks. The first peak 
appeared in fractions 19, 20, 21, and 22, whereas the second peak appeared in fractions 24, 25, 26, and 
27. Fraction 23 marked the boundary between two peaks. 
Analysis of SDS-PAGE gel electrophoresis results for the purification of RctB 
S2-L124-L20M-C-His with Q and SP columns is represented in Figure 13. A band of 14.3 kDa 
size marking RctB S2-L124-L20M-C-His was detected in lanes “19” through “27,” confirming 
the presence of protein in the fractions specified by two peaks. No additional bands were present 
in these lanes, indicating that protein solution was pure and that protein did not degrade during 
the course of the purification process. Analysis of additional fractions using SDS-PAGE gel 
electrophoresis demonstrated that a very negligible amount of RctB S2-L124-L20M-C-His was 
present in those fractions. In the bottom panel of Figure 13, lanes “1” and “7”-“31” exhibit thin  
  
 
 
 
 
 
 
  
Figure 13. Results of SDS-PAGE gel electrophoresis analysis of the purification of RctB 
S2-L124-L20M-C-His using Q and SP columns. Protein marker is shown is lanes marked “PM.” (Top 
panel) Lanes “CL” and “FT” represent samples of column load and column flow through solutions. 
Samples of fractions 18 through 29 are shown in lanes “18”-“29.” Original solution volumes are shown 
on the top of the gel image. (Bottom panel) Additional samples of fractions were taken and studied on a 
separate gel. Lanes “1” through “71” represent samples of specified fractions. Each lane contained 10 µL 
of protein solution sample. Both gels were stained with Coomassie Solution. 
  
 
 
 
 
 
 
bands of 14.3 kDa in size. Together the results of the analysis imply that RctB 
S2-L124-L20M-C-His eluted from SP column in two distinct protein populations that appeared 
to look very similar when evaluated with SDS-PAGE gel electrophoresis. Taking into account 
these results, we decided to pool protein solution from fractions marked by two peaks into 
distinct pools. Thus, we pooled fractions 20, 21, and 22 into Pool # 1 (24 mL) and fractions 24, 
25, and 26 into Pool # 2 (24 mL). 
 To calculate the amount of RctB S2-L124-L20M-C-His in each pool, we measured the 
absorbance of protein solution at 595 nm wavelength using Bradford Method. At 595 nm the 
absorbance of a samples of protein solution from Pool # 1 was 0.5939 and from Pool # 2 the 
absorbance was 06886. Using dilution factor of 1 and protein extinction coefficient of 0.476, we 
calculated protein concentration in Pool # 1 and Pool # 2. The concentration of protein in Pool # 
1 was 1.24 mg/mL, whereas in Pool # 2 the concentration of protein was 1.45 mg/mL. Using the 
volume of each of the solutions (24 mL), we estimated the amount of RctB 
S2-L124-L20M-C-His to be 29.9 mg in Pool #1 and 34.7 mg in Pool # 2. 
Dialysis of RctB S2-L124-L20M at 500 mM sodium chloride resulted in protein solution that did 
not formed a precipitate 
 For dialysis procedure, RctB S2-L124-L20M-C-His protein solution from Pool # 1 was 
divided into two equal parts and dialyzed in buffer containing distinct concentrations of sodium 
chloride. One part of Pool # 1 was dialyzed at 150 mM sodium chloride (Pool # 1a) and another 
part of Pool # 1 was dialyzed at 500 mM sodium chloride (Pool # 1b). RctB 
S2-L124-L20M-C-His from Pool # 2 was dialyzed at 500 mM sodium chloride. After dialysis 
protein solution from three different pools was concentrated in separate concentrators. Pool # 1a 
and Pool # 1b were each concentrated to the final volume of 0.3 mL, whereas Pool #2 was 
concentrated to the final volume of 0.75 mL. To determine whether protein solution can form a 
precipitate, we centrifuged the three pools for 10 minutes in cold room (as described in the 
Methods section). No precipitate was observed in protein solution that was dialyzed in buffer 
containing 500 mM sodium chloride. However, protein solution that was dialyzed in buffer 
containing 150 mM sodium chloride formed a precipitate. 
 To determine the amount of protein obtained after dialysis, we measured protein 
absorbance using Bradford Method and calculated protein concentration. Immediately after 
dialysis, in Pool # 1a and Pool # 1b the absorbance of protein solution at 595 nm was 0.5472 and 
0.6103, respectively.  After dialysis, the concentration of protein in Pool # 1a was 1.15 mg/mL 
and 1.28 mg/mL in Pool # 1b. The net amount of RctB S2-L124-L20M-C-His in Pool # 1A was 
13.8 mg and 16.4 mg in Pool # 1b. In addition, we measured the absorbance of protein solution 
in Pool # 2. After dialysis, the recorded absorbance of protein solution from Pool # 2 was 0.6649, 
  
 
 
 
 
 
 
and the concentration of protein in Pool # 2 was 1.40 mg/mL with a total of 33.5 mg of protein 
(Table 7).  
 
 
Figure # 14. Results of SDS-PAGE gel electrophoresis analysis of RctB S2-L124-L20M-C-His 
before and after dialysis procedure. Lane “PM” represents protein marker. Lanes “Pre-D1” and 
“Pre-D2” specify a sample of SP Column Pool # 1 (fractions 20-22; 24 mL) and a sample of SP Column 
Pool # 2 (fractions 24-26; 24 mL). Samples of protein solution from Pool # 1a (12 mL), Pool # 1b (12 
mL), and Pool # 2 (24 mL) that were collected after dialysis procedure are represented by lanes 
“Post-D1a,” “Post-D1b,” and “Post-D2,” respectively. Lane “1a-20X” specifies 20 times diluted sample 
of protein solution taken from Pool # 1a that had been concentrated to 24.8 mg/mL. Lane “1b-20X” 
indicates sample of protein solution taken from Pool # 1b that had been concentrated to 29.8 mg/mL and 
diluted 20 times. Sample of 20 times diluted protein solution taken from Pool # 2 that was concentrated to 
25.7 mg/mL is represented by lane “2-20X.” Each lane contained 10 L sample of protein solution. Gel 
was stained with Coomassie Solution. 
  
 
 
 
 
 
 
Table 7. Outline of protein concentration measurements made during the purification of RctB 
S2-L124-L20M-C-His.  Absorbance of protein solution was measured at 595 nm wavelength with 
Bradford Method. Protein concentration was calculated using dilution factor and extinction coefficient of 
0.476. 
Solution 
ID 
Volume 
(mL) 
Dilution 
Factor 
Absorbance Concentration 
(mg/mL) 
Amount 
(mg) 
Blank - - 0.0003 - - 
Supernatant 250 5 0.1400 1.47 376.6 
Nickel 
Column 
Pool (E1) 
60 1 0.7718 1.62 97.3 
SP Column 
Pool # 1 
(20, 21, and 
22) 
24 1 0.5939 1.24 29.9 
SP Column 
Pool # 2 
(24, 25, and 
26) 
24 1 0.6886 1.45 34.7 
Post 
Dialysis 
Pool # 1a  
12 1 0.5472 1.15 13.8 
Post 
Dialysis 
Pool # 1b  
12 1 0.6103 1.28 16.4 
Post 
Dialysis  
24 1 0.6649 1.40 33.5 
SP Column 
Pool # 1a 
0.3 20 0.5578 23.44 7.03 
  
 
 
 
 
 
 
Table 8. Protein concentration measurements of final protein product obtained after purification of 
RctB S2-L124-L20M-C-His. Absorbance of protein solution was recorded at 280 nm wavelength with 
UV Spectroscopy Method. Protein concentration was calculated using dilution factor and protein 
extinction coefficient of 0.476. 
Solution 
ID 
Volume 
(mL) 
Dilution 
Factor 
Absorbance Concentration 
(mg/mL) 
Amount 
(mg) 
Blank - - 0.0022 - - 
SP Column 
Pool # 1a 
0.3 20 1.0239 43.0 12.9 
*SP 
Column 
Pool # 1a 
0.3 20 *0.5908 *24.8 *7.45 
Blank - - 0.0017 - - 
SP Column 
Pool # 1b 
0.3 20 0.7088 29.8 8.9 
Blank - - 0.0006 - - 
SP Column 
Pool # 2 
0.75 20 0.6119 25.7 19.3 
 
* UV Spectroscopy graph for SP Column Pool #1a had a high “base line” in comparison to the 
other two graphs (shown below). Protein solution from SP Column Pool # 1a formed a 
precipitate. This suggests that measured absorbance might have been inaccurate. The correct 
absorbance was estimated as follows: Protein Absorbance at 330 nm – Blank Absorbance at 330 
nm = “Base line” difference. Protein Absorbance at 280 nm – “Base line” difference = 
Approximate absorbance of the protein. Using this formula: 0.4357 – 0.0026 = 0.4331 = “Base 
line” difference. 1.0239 – 0.4331 = 0.5908 = Approximate absorbance of SP Column Pool # 1a. 
Thus, final concentration of SP Column Pool # 1a was: 0.5908 * 20 = 11.816 and 11.816/0.476 
= 24.8 mg/mL (total amount of protein = 7.45 mg). Approximate concentration of SP Column 
Pool # 1 compares well with values obtained with Bradford Method (23.44 mg/mL and 7.03 mg). 
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Graph 3. Absorbance of a sample of RctB S2-L124-L20M-C-His protein solution from Pool # 1a at 
estimated concentration of 24.8 mg/mL. The effect of high “base line” is marked with blue arrow. (For 
comparison see Graph 4). 
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Graph 4. Absorbance of a sample RctB S2-L124-L20M-C-His protein solution from Pool # 1b at the 
calculated concentration of 29.8 mg/mL. 
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Graph 5. Absorbance of a sample of RctB S2-L124-L20M-C-His protein solution from Pool # 2 at 
the calculated concentration of 25.7 mg/mL.  
 While concentrating protein solution of the three pools, we made periodic measurements 
of absorbance of protein solution samples from the three pools using Bradford Method and UV 
Spectroscopy Method with an intention to monitor protein concentration and amount of protein 
in the solution. After protein solution was checked for the presence of precipitate, the absorbance 
of protein solution was measured once more. The summary of the final measurements of protein 
concentration in Pool # 1a, Pool # 1b, and Pool # 2 is illustrated in Table 8. Because protein 
solution in Pool # 1a formed a precipitate, the absorbance recordings were inaccurate and graph 
of wavelength vs. absorbance had high "baseline"(see Graph 3). When calculating RctB 
S2-L124-L20M-C-His concentration in Pool # 1a, we took into account the effect of the "base 
line" on the recorded absorbance of the solution sample. To check for accuracy of the calculated 
results, we measured the absorbance of protein solution in Pool # 1a using Bradford Method 
(Table 7). The results of both measurements of protein concentration in Pool # 1a exhibited a 
certain degree of congruency. 
 Using Bradford Method, at 595 nm wavelength, the absorbance of a sample of protein 
solution from Pool # 1a was 0.5578 and the calculated protein concentration was 23.44 mg/mL 
(7.03 mg of protein). The absorbance of a sample of protein solution from Pool # 1a at 280 nm 
wavelength was 1.0239 using UV Spectroscopy Method. When we subtracted the "base line" 
effect, the estimated absorbance was 0.5908, and the calculated protein concentration was 24.8 
  
 
 
 
 
 
 
mg/mL (7.45 mg). Thus, the difference between the two measurements of concentration was 
about 5.6 %, however, we may argue that the concentration of RctB S2-L124-L20M-C-His was 
close to the average of the two measurements (about 24.12 mg/mL). The measured absorbance of 
a sample of protein solution from Pool # 1b was 0.7088 at 280 nm. The estimated concentration 
of RctB S2-L124-L20M-C-His in this pool was 29.8 mg/mL, and the net amount of protein was 
8.9 mg. For Pool # 2, at 280 nm, the measured absorbance was 0.6119. Using this value, we 
estimated that RctB S2-L124-L20M-C-His concentration in Pool # 2 was 25.7 mg/mL with 19.3 
mg of total amount of protein.  
Additionally, we evaluated the effect of dialysis and concentration procedures on the 
quality of final protein product using SDS-PAGE gel electrophoresis. The results of SDS-PAGE 
gel electrophoresis analysis of dialysis procedure are shown in Figure 14. Bands of the size of 
14.3 kDa reflect the presence of RctB S2-L124-L20M-C-His in the specified samples. 
Collectively, the results of dialysis and protein concentration procedures suggest that in order to 
prevent the formation of a precipitate, RctB S2-L124-L20M could be dialyzed in buffer 
containing more than 150 mM sodium chloride. However, taking into account that the precipitate 
could be easily removed by centrifugation, it might not be essential to dialyze this protein 
construct at concentrations of sodium chloride higher than 150 mM. 
Evaluation of the purification of RctB S2-L124-L48M-C-His with Nickel Column revealed that 
protein bound to Nickel beads and eluted at 500 mM imidazole 
 We purified cell extract of the BL21 cells that were transformed with pNO017 and 
induced to express RctB S2-L124-L48M-C-His with Nickel Column in a similar manner as 
described for RctB S2-L124-C-His construct. Even though the new construct contained L48M 
mutation and was labeled with SeMet, we expected that, since this construct contained His tag, it 
would be able to bind Nickel beads. The results of the purification of RctB 
S2-L124-L48M-C-His using Nickel column were analyzed with SDS-PAGE gel electrophoresis 
and are illustrated in Figure 15. According to the results of the analysis, most of the  RctB 
S2-L124-L48M-C-His protein solution eluted in the flow through solution of Elution Buffer 1, 
containing 500 mM imidazole. Lanes “S” and “E1” in Figure 15 feature prominent bands of 14.3 
kDa in size, marking RctB L2-L124-L48M-C-His and confirming the presence of this protein in 
column load and final pool. No additional bands were detected in lane “E1.” This suggests that 
after purification with Nickel Column, RctB S2-L124-L48M-C-His protein solution contained 
very little amount of contaminant proteins. The presence of faint bands of 14.3 kDa were also 
observed in lane “P,” implying that some RctB S2-L124-L48M-C-His was lost in cell pellet.  
 Although the presence of RctB S2-L124-L48M-C-His was detected in lanes“W5” and 
“E2,” the protein solutions represented by these lanes were not included in the final pool for the 
  
 
 
 
 
 
 
following reasons. The amount of protein in the solutions, marked by “W5” and “E2,” in all 
likelihood contained negligible amount of RctB S2-L124-L48M-C-His. In addition, protein 
solution from the flow through of Wash Buffer 5 was likely to contain contaminant proteins. 
Finally, since it was necessary to dilute Nickel column pool prior to the subsequent experiment, 
the purification procedure might have been considerably extended and thereby affected the 
quality of the final protein product. Taken together, the results of the SDS-PAGE gel 
electrophoresis analysis of the purification of RctB S2-L124-L48M-C-His with Nickel Column 
indicate that this RctB construct bound Nickel beads efficiently and was eluted from the column 
at 500 mM imidazole. 
 
Figure 15. Results of SDS-PAGE gel electrophoresis analysis of the purification of RctB 
S2-L124-L48M-C-His using Nickel Column. Lane "M" designates protein marker. Lanes "P" and "S" 
specify samples of cell pellet and cell supernatant, respectively. Sample of initial column flow through is 
represented in lane "FT." Lanes "W1" -"W5" represent samples of the flow through solutions collected 
after Wash Buffers 1-5 were poured into the column, and lanes "E1," "E2," and "E3" indicate samples of 
the flow through solution collected after Elution Buffers 1-3 were poured into the column. All samples 
were run on 15% SDS-PAGE gel and stained with Coomassie Solution. Each well contained 10 L 
sample of protein solution. 
 To estimate the amount of RctB S2-L124-L48M-C-His obtained after purification 
procedure involving Nickel Column, we measured the absorbance at 595 nm wavelength of a 
  
 
 
 
 
 
 
sample of protein solution from the flow through of Elution Buffer 1. The recorded absorbance 
of protein solution was 0.9646. Using dilution factor of 1 and protein extinction coefficient of 
0.476, we estimated that the concentration of RctB S2-L124-L48M-C-His solution obtained after 
purification of this protein construct with Nickel Column was 2.03 mg/mL. Since the total 
volume of protein solution was 30 mL, the net amount of protein was estimated to be 60.79 mg. 
Summary of protein concentration measurements is provided in Table 9. 
The results of purification of RctB S2-L124-L48M-C-His with Q and SP Columns were similar to 
the outcome of the purification of RctB S2-L124-L20M-C-His 
 We purified RctB S2-L124-L48M-C-His protein solution, obtained from purification 
procedure involving Nickel Column, using Q and SP Columns in a similar manner as described 
for the purification of the other two RctB constructs. The results of AKTA FPLC computer 
evaluation of the purification of RctB S2-L124-L48M-C-His are featured in Figure 16. 
According to the results of AKTA FPLC computer evaluation, protein solution eluted in two 
peaks. The first peak appeared over fractions B5, B4, and B3, whereas the second peak appeared 
over fractions B2, B1, and C1. Notably, the first peak was higher than the second peak, which is 
an exemplar of disparity from the previous purification of RctB constructs with Q and SP 
Columns. 
 
Figure 16. AKTA FPLC computer evaluation of the purification of RctB S2-L124-L48M-C-His 
using Q and SP Columns. The amount of protein eluted from the SP Column is represented with a blue 
line. Solution conductivity is indicated with a brown line. Column fractions are marked on the bottom of 
the graph. As shown on the graph, RctB S2-L124-L20M-C-His eluted in two peaks. The first peak 
appeared in fractions B5, B4, and B3, whereas the second peak appeared in fractions B2, B1, and C1.  
  
 
 
 
 
 
 
 
Figure 17. Results of SDS-PAGE gel electrophoresis analysis of the purification of RctB 
S2-L124-L48M-C-His using Q and SP columns. Protein marker is shown is lanes marked “M.” (Top 
panel) Lanes “L” and “FT” represent samples of column load and column flow through solutions. 
Samples of fractions B7 through B1 and C1 through C5 are shown in lanes “B7”-“B1,” and “C1” - “C5,” 
respectively. (Bottom panel) Additional samples of fractions were taken and studied on a separate gel. 
Lanes “A1” through “F2” represent samples of specified fractions. Each lane contained 10 µL of protein 
solution sample. Both gels were stained with Coomassie Solution. 
  
 
 
 
 
 
 
 To determine whether RctB S2-L124-L48M-C-His protein was present in the fractions 
specified by the two peaks, we performed SDS-PAGE gel electrophoresis. The results of the 
SDS-PAGE gel electrophoresis analysis of select SP column fractions is featured in Figure 17. 
The presence of thick, 14.3 kDa bands in lanes “B5” through “C1” confirmed the presence of 
RctB S2-L124-L48M-C-His protein in the fractions marked by the two peaks. Attesting the 
presence of target protein in the column load solution, a similar band was detected in lane “L.”  
No band of the size of 14.3 kDa was visible in lane “FT,” implying that RctB 
S2-L124-L48M-C-His bound to the SP Column efficiently and was not lost in the initial flow 
through solution. Protein was also detected in fractions B6 and C2-C5. However, the bands 
specifying the protein were rather faint, so these fractions were not pooled. Instead, fraction 
B5-B3, marked by the first peak, were pooled into Pool # 1 (24 mL), whereas fractions B2, B1, 
C1, and C2, marked by the second peak were pooled into Pool # 2 (24 mL). Using Bradford 
Method, we estimated the concentration and the amount of protein solution in Pool # 1 and Pool 
# 2. The calculated protein concentration in Pool # 1 was 1.52 mg/mL and 1.07 mg/mL in Pool # 
1. Since the volume of each solution was 24 mL, there was about 36.40 mg of RctB 
S2-L124-L48M-C-His in Pool #1 and 25.75 mg in Pool # 2 (Table 9).  
After dialysis and concentration, RctB S2-L124-L48M-C-His from Pool #1 formed a precipitate 
at 150 mM sodium chloride 
 RctB S2-L124-L48M-C-His protein solution in Pool # 1 and Pool # 2 was dialyzed at 
different concentrations of sodium chloride. Specifically, protein solution from Pool # 1 was 
dialyzed in a buffer containing 150 mM sodium chloride, whereas protein solution from Pool # 2 
was dialyzed in a buffer containing 500 mM sodium chloride. The decision regarding the dialysis 
of protein solution was made rather arbitrarily with the following motives. First, we were 
interested to determine whether RctB S2-L124-L48M-C-His from Pool # 1 will form a 
precipitate at 150 mM sodium chloride. Second, we aimed to obtain a greater amount of protein 
for the crystallization experiments, so dividing protein solution from Pool #1 and dialyzing it at 
distinct sodium chloride concentrations would have required to treat the resulting solutions as 
distinct pools. Third, since protein solution from Pool # 2 of RctB-S2-L124-C-His construct had 
a tendency to precipitate during concentration procedures when dialyzed at 150 mM sodium 
chloride, we decided to dialyze Pool # 2 at 500 mM sodium chloride.  
 The outcomes of dialysis and concentration procedures were evaluated using SDS-PAGE 
gel electrophoresis. The results of SDS-PAGE gel electrophoresis analysis of dialysis and 
concentration procedures are shown in Figures 18 and 19. Lanes “1-preD” and “1-postD” 
confirm the presence of RctB S2-L124-L48M-C-His in Pool # 1 before and after dialysis. 
Similarly, lanes “2-preD” and “2-postD” verify the presence of target protein in Pool # 2. 
  
 
 
 
 
 
 
Measurements of protein concentration after dialysis revealed that protein concentration in Pool 
# 1 was 1.42 mg/mL, whereas protein concentration in Pool # 2 was 1.15 mg/mL, as shown in 
Table 9. Slight differences in the results of concentration measurements that were made before 
and after dialysis were observed in Pool # 2. These differences might have resulted from 
insufficient mixing of sample of Pool # 2 when absorbance of protein solution sample was 
measured before dialysis. Overall, only small amount of protein was lost during the course of 
dialysis of Pool # 1.  
 
Figure # 18. Results of SDS-PAGE gel electrophoresis analysis of RctB S2-L124-L48M-C-His 
before and after dialysis procedure. Lane “M” indicates protein marker. Lanes “1-PreD” and “1-PostD” 
specify samples of SP Column Pool # 1 (fractions B5, B4, and B3; 24 mL) taken before and after dialysis, 
respectively. Lanes “2-preD” and “2-postD” represent samples of SP Column Pool # 2 (fractions B2, B1, 
and C1; 24 mL) taken before and after dialysis accordingly. SP Column Pool #1 was dialyzed at 150 mM 
NaCl, whereas SP Column Pool # 2 was dialyzed at 500 mM NaCl. Each lane contained 10 L sample of 
protein solution. Gel was stained with Coomassie Solution. 
  
 
 
 
 
 
 
Table 9. Summary of protein concentration measurements made during the purification of RctB 
S2-L124-L48M-C-His.  Absorbance of protein solution was measured at 595 nm wavelength with 
Bradford Method. Protein concentration was calculated using dilution factor and extinction coefficient of 
0.476. 
Solution ID Volume (mL) Dilution 
Factor 
Absorbance Concentration 
(mg/mL) 
Amount (mg) 
Blank - - 0.0006 - - 
Supernatant 250 5 0.1934 2.03 507.88 
Nickel Column 
Pool (E1) 
30 1 0.9646 2.03 60.79 
SP Column 
Pool # 1 (B5, 
B4, B3) 
24 1 0.7219 1.52 36.40 
SP Column 
Pool # 2 (B2, 
B1, C1) 
24 1 0.5108 1.07 25.75 
Post Dialysis 
Pool # 1 (150 
mM NaCl) 
24 1 0.6756 1.42 34.06 
Post Dialysis 
Pool # 2 (500 
mM NaCl) 
24 1 0.5487 1.15 27.67 
 
Table 10. Protein concentration measurements of final protein product obtained after purification 
of RctB S2-L124-L48M-C-His. Absorbance of protein solution was recorded at 280 nm wavelength with 
UV Spectroscopy Method. Protein concentration was calculated using dilution factor and protein 
extinction coefficient of 0.476. 
Solution ID Volume (mL) Dilution 
Factor 
Absorbance Concentration 
(mg/mL) 
Amount (mg) 
Blank - - 0.0088 - - 
Pool # 1 1.2 20 0.4977 20.91 25.09 
Blank - - 0.0013 - - 
Pool # 2 0.6 20 0.7257 30.49 18.29 
 
 After dialysis, protein solution in Pool # 1 and Pool # 2 were concentrated in separate 
concentrators until the final volume of 1.2 mL and 0.6 mL, respectively. To check for precipitate 
  
 
 
 
 
 
 
formation, protein solution was centrifuged for 10 minutes at 14,000 rpm in the cold room. 
Precipitate was observed in the form of a pellet for in Pool #1. No precipitate was detected in 
Pool # 2. Subsequently, protein solution was transferred into fresh tubes. Samples of pellet and 
protein solution were analyzed with SDS-PAGE gel electrophoresis (see Figure 19). UV 
Spectroscopy Method was used to determine final protein concentration (see Table 10 and 
Graphs 6-7).  
 
Figure 19.  Results of SDS-PAGE gel electrophoresis analysis of final purification product of RctB 
S2-L124-L48M-C-His. Lanes “M” and “P” specify protein marker, and a sample of precipitate pellet 
formed after Pool # 1 was centrifuged for 10 minutes, at 14,000 rpm and 4 oC, respectively. Lanes “1-5X” 
and “2-5X” represent 5 times diluted samples of protein solution from Pool # 1 and Pool # 2, accordingly. 
Each lane contained 10 L sample of protein solution. Coomassie Solution was used to stain the gel. 
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Graph 6. Absorbance of a sample of RctB S2-L124-L48M-C-His protein solution from Pool # 1 at 
the calculated concentration of 20.91 mg/mL.  
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Graph 7. Absorbance of a sample of RctB S2-L124-L48M-C-His protein solution from Pool # 2 at 
the calculated concentration of 30.49 mg/mL. 
  
 
 
 
 
 
 
Evaluation of the purification of RctB S2-L124-L20M-L48M-C-His with Nickel Column revealed 
that this protein bound Nickel beads and eluted at 500 mM imidazole 
 
Figure 20. Results of SDS-PAGE gel electrophoresis analysis of the purification of RctB 
S2-L124-L20M-L48M-C-His using Nickel Column. Lane "M" specifies protein marker. Lanes "P" and 
"S" indicate samples of cell pellet and cell supernatant, respectively. Sample of initial column flow 
through solution is represented in lane "FT." Lanes "W1" -"W5" mark samples of the flow through 
solutions collected after Wash Buffers 1-5 were poured into the column, whereas lanes "E1," "E2," and 
"E3" mark samples of the flow through solution collected after Elution Buffers 1-3 were poured into the 
column. All samples were run on 15% SDS-PAGE gel and stained with Coomassie Solution. 
We purified RctB S2-L124-L20M-L48M-C-His in a comparable manner as the other 
three RctB constructs. Even though the present RctB construct contained L20M and L48M 
substitutions, the results of purification procedures involving Nickel Column were similar to the 
results of the other protein purification experiments that involved this method, as described 
above. The results of the SDS-PAGE gel electrophoresis analysis of the purification of RctB 
S2-L124-L20M-L48M-C-His using Nickel Column are shown in Figure 20. A band of 14.3 kDa 
in size was detected in lanes “P,” “S,” and “E1,” indicating the presence of RctB 
  
 
 
 
 
 
 
S2-L124-L20M-L48M-C-His in cell pellet, cell supernatant and the flow through from Elution 
Buffer # 1. The presence of this band in lane “P” suggests that certain amount of protein was lost 
in the cell pellet. No band of the size of 14.3 kDa was detected in lane “FT,” implying that 
RctB-S2-L124-L20M-L48M-C-His bound to the Nickel beads. According to the results of 
SDS-PAGE gel electrophoresis analysis of the purification of RctB 
S2-L124-L20M-L48M-C-His, nearly all protein solution eluted in the flow through of Elution 
Buffer 1, at 500 mM imidazole. 
 RctB S2-L124-L20M-L48M-C-His concentration in cell supernatant and Nickel Column 
pool (E1, 30 mL) was calculated by measuring the absorbance of samples of protein solution at 
595 nm wavelength. The estimated concentration of protein in the cell supernatant was 2.33 
mg/mL. Since the total volume of the cell supernatant was 90 mL, the initial amount of protein 
was 209.87 mg. The concentration of RctB S2-L124-L20M-L48M-C-His in Nickel Column pool 
was 0.704 mg/mL, and the net amount of purified protein was 21.11 mg. 
Purification of RctB S2-L124-L20M-L48M-C-His with Q and SP column resulted in a single 
protein population. 
 
Figure 21. AKTA FPLC computer evaluation of the purification of RctB 
S2-L124-L20M-L48M-C-His using Q and SP Columns. The amount of protein eluted from the SP 
Column is represented with a blue line. Solution conductivity is indicated with a brown line. Column 
fractions are marked on the bottom of the graph. RctB S2-L124-L20M-L48M-C-His eluted in a single 
peaked that is positioned over fractions B4, B3, B2, and B1. 
  
 
 
 
 
 
 
 
Figure 22. Results of SDS-PAGE gel electrophoresis analysis of the purification of RctB 
S2-L124-L20M-L48M-C-His using Q and SP columns. Protein marker is shown is lanes marked “M.” 
(Top panel) Lanes “L” and “FT” indicate samples of column load and column flow through solutions. 
Samples of fractions A1, A2, B6 through B1, and C1 through C4 are shown in lanes designated lanes. 
(Bottom panel) Additional samples of fractions were taken and evaluated on a separate gel. Lanes “A3” 
through “F2” represent samples of specified fractions. Each lane contained 10 µL of protein solution 
sample. Both gels were stained with Coomassie Solution. 
  
 
 
 
 
 
 
 After purification method involving Nickel Column, RctB S2-L124-L20M-L48M-C-His 
was further purified with Q and SP Columns. Since this method of purification had produced 
distinctive protein populations previously, we expected that the results of purification of RctB 
S2-L124-L20M-L48M-C-His will be analogous to the former results. However, the results of the 
purification of this RctB protein construct were distinct from the results of purification of the 
other three RctB constructs. As illustrated in Figure 21, AKTA FPLC computer evaluation of the 
outcome of protein purification with SP column revealed that protein eluted in a single peak and 
indicated that target protein was present in fractions B4, B3, B2, and B1. 
 Using SDS-PAGE gel electrophoresis, we evaluated samples of fractions from SP 
Column for the presence of RctB S2-L124-L20M-L48M-C-His. The results of SDS-PAGE gel 
electrophoresis analysis are shown in Figure 22. Bands of the size of 14.3 kDa, marking RctB 
S2-L124-L20M-L48M-C-His, were detected in lanes “L,” “B5” to “B1,” and “C1” to “C3.” 
Protein solution from fractions B4, B3, and B2 was pooled for subsequent procedures. The 
estimated concentration of RctB S2-L124-L20M-L48M-C-His in SP Column pool was 0.424 
mg/mL. Since the total volume of the pool was 24 mL, the total amount of protein in the pool 
was 10.14 mg. 
After dialysis and concentration procedures, RctB S2-L124-L20M-L48M-C-His formed a 
precipitate at both 150 mM and 500 mM sodium chloride 
 SP Column pool was divided into two equal parts of approximately 12 mL each and was 
placed to dialyze in buffers containing distinct concentrations of sodium chloride. One part of 
protein solution was dialyzed in buffer containing 150 mM sodium chloride (Pool # 1), whereas 
the second part of protein solution was dialyzed in buffer containing 500 mM sodium chloride 
(Pool # 2). The results of SDS-PAGE gel electrophoresis analysis of samples of RctB 
S2-L124-L20M-L48M-C-His taken before and after dialysis procedures are represented in 
Figure 23. Lane “Pre-D,” specifying a sample of SP Column pool, and lanes “Post-D1” and 
“Post-D2,” indicating samples of Pool # 1 and Pool # 2, each contained a band of 14.3 kDa in 
size. No additional bands were detected in these lanes, implying that protein collected after 
purification with SP column and dialysis procedures was very pure.  
 Protein solutions from Pool # 1 and Pool # 2 were concentrated in different concentrators 
until the final volumes of 0.300 mL and 0.150 mL, respectively. To check for precipitate, protein 
solution was centrifuged in cold room for 10 minutes at 14,000 rpm. A precipitate was observed 
in solutions from both Pool # 1 and Pool # 2. After centrifugation protein solutions were 
transferred into fresh tubes and final protein concentration was measured with Bradford Method. 
Protein concentration measurements were attempted using UV Spectroscopy Method, but the 
measured absorbance of each solution yielded inconclusive results, possibly for the presence of 
  
 
 
 
 
 
 
trace amounts of protein precipitate in the samples. Nonetheless, the final estimated protein 
concentration in Pool # 1 was 5.91 mg/mL and 9.95 mg/mL in Pool # 2. Summary of protein 
concentration measurements made during the course of purification of RctB 
S2-L124-L20M-C-His is presented in Table 11.  
 
Figure 23. Results of SDS-PAGE gel electrophoresis analysis of RctB S2-L124-L20M-L48M-C-His 
before and after dialysis procedure. Lane “M” represents protein marker. Samples of protein solution 
taken from SP Column pool (fractions B4-B2, 24 mL) is featured in lane “Pre-D.” Lanes “Post-D1” and 
“Post-D2” represent samples of protein solution collected after dialysis from Pool # 1 and Pool # 2, 
respectively. Each lane contained 10 µL of protein solution sample. Coomassie Solution was used to stain 
the gel. 
  
 
 
 
 
 
 
Table 11. Summary of protein concentration measurements made during the purification of RctB 
S2-L124-L20M-L48M-C-His.  Absorbance of protein solution was measured at 595 nm wavelength 
using Bradford Method. Protein concentration was determined using dilution factor and extinction 
coefficient of 0.476. 
Solution ID Volume (mL) Dilution 
Factor 
Absorbance Concentration 
(mg/mL) 
Amount (mg) 
Blank - -    
Supernatant 90 5 0.2220 2.33 209.87 
Nickel Column 
Pool (E1) 
30 1 0.3349 0.704  
SP Column 
Pool (B4-B2)  
24 1 0.2011 0.423 10.14 
Post Dialysis 
Pool # 1 (150 
mM NaCl) 
10 1 0.2138 0.449 4.49 
Post Dialysis 
Pool # 2 (500 
mM NaCl) 
12.5 1 0.2376 0.499 6.24 
Final Pool # 1 
(150 mM 
NaCl) 
0.300 5 0.5626 5.91 1.77 
Final 
Pool # 2 (500 
mM NaCl) 
0.150 5 0.9471 9.95 1.49 
 
Results of the Protein Crystallization Experiments 
 The results of crystallization experiments involving four different RctB constructs shared 
some similarities and differences. Several screens were used for crystallization experiments 
involving the four RctB constructs. In this report, we will focus on screens that produced top 
results and illustrate some of the representative observations that were made in the crystallization 
plates that were prepared using those screens. Each crystallization plate contained 96 wells, 
which permitted the testing of 96 possible conditions necessary for the growth of protein crystals 
for every protein sample used during the experiment. The results observed in each well were 
scored on a scale 1 to 10, specifying observations ranging from clear drop to single crystals that 
are appropriate for X-ray crystallography experimentations. Table 12 illustrates the scoring 
legend used for evaluation of the results of crystallization experiments. 
  
 
 
 
 
 
 
The outcome of crystallization experiments involving RctB S2-L124-C-His revealed a 
high number of positive hits. The best results were achieved with optimized screen 14 071614 
NO RN OPT 1 (Dr. Jeruzalmi’s Laboratory). This screen was specifically designed for RctB 
S2-L124-C-His protein construct on the basis of the results that were attained from the use of 
other screens. A great proportion of wells in the crystallization plate that was set up with this 
screen contained clusters of protein crystals, plates, and needles in addition to microcrystals. 
However, no single crystal, suitable for the X-ray crystallography trials, was found in the 
crystallization plates that were set up with RctB S2-L124-C-His construct. Figure 24 
demonstrates examples of protein crystals that formed from RctB S2-L124-C-His protein 
solution (Pool # 1) in a crystallization plate that was prepared using 14 071614 NO RN OPT 1 
screen. 
 
Figure 24. Example of the results of crystallization experiment using RctB S2-L124-C-His. 
Crystallization plate was prepared using optimized screen. (A). Cluster of crystals. (B). Plates. (C). 
Needles. (D). Microcrystals.  Image FOV (height) is 3.10 mm. 
  
 
 
 
 
 
 
 The results of the crystallization experiments involving RctB S2-L124-L20-M-C-His did 
not yield a very high number of good-quality crystals. The best results of crystallization 
experiments involving this protein construct were attained with optimized screen 14 071614 NO 
RN OPT 1. In the crystallization plate prepared with this screen, most wells received a score of 8 
or below. The premium protein crystals that received a score of “8” resembled thin plates. Other 
crystals that received a score of “7” had needle-like form. Select examples of the results of the 
crystallization experiment involving RctB S2-L124-L20-M-C-His (Pool 1a) and 14 071614 NO 
RN OPT 1 screen are featured in Figure 25. 
 
Figure 25. Example of the results of crystallization experiment using RctB S2-L124-L20M-C-His. 
Crystallization plate was prepared using optimized screen. (A). Plates. (B). Needles. (C). Crystalline 
precipitate (D). Phase separation.  Image FOV (height) is 3.10 mm. 
  
 
 
 
 
 
 
 Crystallization investigations involving the RctB S2-L124-L48M-C-His produced 
prodigious results. Of the assortment of screens that were used to grow protein crystals with 
RctB S2-L124-L48M-C-His, optimum results were attained with commercial screen PEGS 
(Qiagen). Single crystal that received a score of 10 was discovered in one of the wells of the 
crystallization plate that was prepared using PEGS screen and a frozen sample of RctB 
S2-L124-L48M-C-His. Clusters of crystals, plates, and needles were also detected in great 
proportion in wells of the crystallization plate. Figure 26 shows examples of protein crystals that 
formed from RctB S2-L124-L48M-C-His construct in a crystallization plate that was set up with 
PEGS screen.  
 
Figure 26. Example of the results of crystallization experiment using RctB S2-L124-L48M-C-His. 
Crystallization plate was prepared using optimized screen. (A). Single crystal. (B). Cluster of crystals. 
(C). Plates (D). Needles.  Image FOV (height) is 3.10 mm. 
  
 
 
 
 
 
 
 
Figure 27. Example of the results of crystallization experiment using RctB 
S2-L124-L20M-L48M-C-His. Crystallization plate was prepared using optimized screen. (A). Needles. 
Arrowhead points to the location of needle-like crystals. (B). Crystalline precipitate. (C). Precipitate. (D). 
Clear drop.  Image FOV (height) is 3.10 mm. 
 RctB S2-L124-L20M-L48M-C-His construct was more challenging for the crystallization 
experiments than the other three RctB constructs. Only few small crystals were found in the 
crystallization plate that was set up using 14 071614 NO RN OPT 1 screen. Figure 27 illustrates 
representative results from the crystallization experiments involving RctB 
S2-L124-L20M-L48M-C-His. Nevertheless, crystals in the shape of needles and crystalline 
precipitate were discovered in some of the wells. These results indicate that RctB 
S2-L124-L20M-L48M-C-His can be crystallized under specific circumstances. In order to obtain 
high-quality crystals with RctB S2-L124-L20M-L48M-C-His construct, it would be necessary to 
  
 
 
 
 
 
 
test additional screens. This would require a higher amount of protein than was originally 
obtained during the purification of this RctB construct. Consequently, it is imperative to optimize 
protein purification strategies in order to acquire higher amount of the protein. Introducing minor 
changes into the original protein purification protocol, such as using a greater amount of cells 
and Nickel beads during initial stages of protein purification, might result in higher protein yield.  
Table 12. Scoring legend used to evaluate the results of protein crystallization experiments. 
 
 Evaluation of the conditions that facilitated the growth of protein crystals of the RctB 
constructs that were described in this report can provide valuable information for development of 
optimized screens that could be used for additional studies involving RctB protein. Furthermore, 
high-quality protein crystal that was acquired with RctB S2-L124-L48M-C-His construct can be 
implemented for forthcoming X-ray crystallography experiments that intend to unveil RctB 
structural components. Finally, the results of the crystallization experiments described in this 
report can serve as a guidance for further studies involving RctB protein.   
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